GT,Diagnosis 1,ERN Category
['Vitamin B12-unresponsive methylmalonic acidemia'],"+1 Methylmalonic Acidemia (MMA): Metabolic acidosis, decreased methylmalonyl-CoA mutase activity, death in infancy and childhood. Key symptoms not reported: Neurological symptoms, failure to thrive, vomiting. 
+2 Propionic Acidemia: Metabolic acidosis, potential overlap with decreased methylmalonyl-CoA mutase activity. Key symptoms not reported: Hypoglycemia, ketonuria. 
+3 Isovaleric Acidemia: Metabolic acidosis, potential overlap with metabolic disturbances. Key symptoms not reported: Sweaty feet odor, acute metabolic crises. 
+4 Maple Syrup Urine Disease: Metabolic acidosis, potential overlap with amino acid metabolism issues. Key symptoms not reported: Distinctive sweet-smelling urine, neurological decline. 
+5 Urea Cycle Disorders: Metabolic acidosis, potential overlap with metabolic disturbances. Key symptoms not reported: Hyperammonemia, altered mental status.",Hereditary metabolic disorders
['Succinic semialdehyde dehydrogenase deficiency'],"+1 Organic acidemia: This diagnosis aligns with elevated urinary carboxylic acid, motor delay, and hypotonia. Key symptoms not reported may include metabolic crises or specific episodes of illness. 
+2 Spinal muscular atrophy (SMA): Consistent with motor delay and generalized hypotonia. Key symptoms not reported may include progressive weakness and respiratory difficulties. 
+3 Mitochondrial disorder: Fits with hypotonia and motor delay, and could explain pneumonia. Key symptoms not reported may include exercise intolerance or seizures. 
+4 Glycogen storage disease: Could explain hypotonia and motor delay. Key symptoms not reported may include hepatomegaly or hypoglycemic episodes. 
+5 Urea cycle disorder: May account for hypotonia and metabolic derangements. Key symptoms not reported may include episodes of vomiting or altered mental status.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Tyrosinemia Type I: This condition is consistent with hypertyrosinemia and can lead to neonatal death. Key symptoms not reported include liver dysfunction and failure to thrive.
+2 Phenylketonuria (PKU): Hyperphenylalaninemia aligns with this diagnosis, but the severity of other symptoms suggests a more complex disorder. Key symptoms not reported include developmental delays if untreated.
+3 Maple Syrup Urine Disease (MSUD): This condition can lead to severe neurological impairment and death in infancy, but does not typically present with hypertyrosinemia. Key symptoms not reported include characteristic sweet-smelling urine.
+4 Galactosemia: While this can lead to death in infancy, it does not explain the hypertyrosinemia or hyperphenylalaninemia. Key symptoms not reported include jaundice and feeding difficulties.
+5 Congenital Disorders of Glycosylation: These can present with a variety of symptoms, but the specific combination here is more indicative of a specific metabolic disorder. Key symptoms not reported include developmental delays and failure to thrive.",Hereditary metabolic disorders
['PMM2-CDG'],"+1 Congenital Muscular Dystrophy: Symptoms consistent include motor delay and abnormal muscle physiology. Key symptoms not reported may include muscle weakness and joint contractures. 
+2 Fryns Syndrome: Symptoms consistent include congenital diaphragmatic hernia and failure to thrive. Key symptoms not reported may include facial dysmorphism and limb abnormalities. 
+3 Bardet-Biedl Syndrome: Symptoms consistent include motor delay and failure to thrive. Key symptoms not reported may include obesity and retinal dystrophy. 
+4 Cerebellar Agenesis: Symptoms consistent include cerebellar atrophy and motor delay. Key symptoms not reported may include ataxia and developmental delays. 
+5 Metabolic Disorder (e.g., Lipodystrophy): Symptoms consistent include lipodystrophy and failure to thrive. Key symptoms not reported may include insulin resistance and dyslipidemia.",Hereditary metabolic disorders
['Maple syrup urine disease'],"+1 Maple Syrup Urine Disease (MSUD): Symptoms consistent include hypervalinemia, hyperleucinemia, and developmental delays. Key symptoms not reported include a characteristic sweet-smelling urine.
+2 Organic Acidemia: Symptoms consistent include elevated urinary carboxylic acid and neurological symptoms. Key symptoms not reported may include metabolic crises or acidosis.
+3 Urea Cycle Disorder: Symptoms consistent include neurological impairment and developmental delays. Key symptoms not reported include hyperammonemia.
+4 Congenital Disorders of Glycosylation: Symptoms consistent include developmental delays and hypotonia. Key symptoms not reported include specific dysmorphic features or systemic involvement.
+5 Mitochondrial Disorder: Symptoms consistent include developmental delays and hypotonia. Key symptoms not reported may include exercise intolerance or specific organ dysfunction.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Phenylketonuria (PKU): Symptoms consistent include hyperphenylalaninemia, skin rash, and obesity. Key symptoms not reported include neurological symptoms or developmental delays. 
+2 Tyrosinemia: Symptoms consistent include hypertyrosinemia, gastrointestinal inflammation, and skin rash. Key symptoms not reported include liver dysfunction or failure to thrive. 
+3 Cystic Fibrosis: Symptoms consistent include gastrointestinal inflammation and recurrent infections. Key symptoms not reported include respiratory symptoms or pancreatic insufficiency. 
+4 Metabolic Syndrome: Symptoms consistent include obesity and skin rash. Key symptoms not reported include insulin resistance or dyslipidemia. 
+5 Inborn Errors of Metabolism: Symptoms consistent include metabolic abnormalities and history of neonatal death. Key symptoms not reported include specific metabolic crisis episodes or organ dysfunction.",Hereditary metabolic disorders
['Biotinidase deficiency'],"+1 Mitochondrial disorder: Increased circulating lactate concentration, increased CSF lactate. Key symptoms not reported: Neurological deficits, exercise intolerance. 
+2 Genetic syndrome (e.g., Chédiak-Higashi syndrome): Eczematoid dermatitis, alopecia. Key symptoms not reported: Immunodeficiency, recurrent infections. 
+3 Metabolic disorder (e.g., pyruvate dehydrogenase deficiency): Increased circulating lactate concentration, increased CSF lactate. Key symptoms not reported: Neurological symptoms, developmental delays. 
+4 Autoimmune condition (e.g., lupus erythematosus): Skin rash, alopecia. Key symptoms not reported: Joint pain, systemic symptoms (fever, fatigue). 
+5 Nutritional deficiency (e.g., biotin deficiency): Eczematoid dermatitis, alopecia. Key symptoms not reported: Neurological symptoms, hair loss patterns.",Hereditary metabolic disorders
['PMM2-CDG'],"+1 Bardet-Biedl Syndrome: Symptoms consistent include rod-cone dystrophy, intellectual disability, and abnormal facial shape. Key symptoms not reported include obesity and polydactyly. 
+2 Alström Syndrome: Symptoms consistent include rod-cone dystrophy, intellectual disability, and liver dysfunction. Key symptoms not reported include cardiomyopathy and hearing loss. 
+3 Meckel-Gruber Syndrome: Symptoms consistent include cerebellar agenesis and abnormal facial morphology. Key symptoms not reported include cystic kidney disease and polydactyly. 
+4 Cerebrohepatorenal Syndrome: Symptoms consistent include cerebellar atrophy, liver dysfunction, and intellectual disability. Key symptoms not reported include specific dysmorphic features and renal anomalies. 
+5 Kearns-Sayre Syndrome: Symptoms consistent include retinal degeneration and cerebellar atrophy. Key symptoms not reported include cardiac conduction defects and ophthalmoplegia.",Hereditary metabolic disorders
['Glutaryl-CoA dehydrogenase deficiency'],"+1 Glutaric Aciduria Type I: Symptoms consistent include lethargy, generalized hypotonia, dystonia, and history of glutaric aciduria. Key symptoms not reported may include metabolic crisis signs such as acidosis or seizures. 
+2 Cystic Fibrosis: Symptoms consistent include diarrhea and dyspnea. Key symptoms not reported may include recurrent respiratory infections or failure to thrive. 
+3 Neurodegenerative Disorders: Symptoms consistent include lethargy, generalized hypotonia, and dystonia. Key symptoms not reported may include progressive weakness or loss of motor skills. 
+4 Infectious Process: Symptoms consistent include fever, vomiting, diarrhea, and dyspnea. Key symptoms not reported may include signs of meningitis or sepsis such as neck stiffness or altered mental status. 
+5 Congenital Malformation Syndromes: Symptoms consistent include macrocephaly and cystic hygroma. Key symptoms not reported may include other physical anomalies or developmental delays.",Hereditary metabolic disorders
['Isovaleric acidemia'],"+1 Urea Cycle Disorder: Symptoms include hyperammonemia, lethargy, and feeding difficulties. Key symptoms not reported include vomiting and irritability. 
+2 Glycine Encephalopathy: Symptoms include abnormal circulating glycine concentration, lethargy, and drowsiness. Key symptoms not reported include seizures and hypotonia. 
+3 Organic Acidemia: Symptoms include lethargy, feeding difficulties, and death in infancy. Key symptoms not reported include metabolic acidosis and ketonuria. 
+4 Fatty Acid Oxidation Disorder: Symptoms include lethargy, drowsiness, and feeding difficulties. Key symptoms not reported include hypoglycemia and cardiomyopathy. 
+5 Mitochondrial Disorder: Symptoms include lethargy, sleep abnormalities, and death in childhood. Key symptoms not reported include muscle weakness and exercise intolerance.",Hereditary metabolic disorders
['PMM2-CDG'],"+1 Cerebellar agenesis: This condition explains the cerebellar atrophy, ataxia, and hypotonia. Key symptoms not reported include seizures, which can occur in some cases.
+2 Miller-Dieker syndrome: This genetic syndrome correlates with microcephaly, intellectual disability, and growth delay. Key symptoms not reported include facial dysmorphism.
+3 Congenital infections (e.g., Zika virus): This could explain microcephaly and neurological symptoms. Key symptoms not reported include rash or other signs of infection during pregnancy.
+4 Metabolic disorders (e.g., mitochondrial disorders): These can lead to hypotonia and developmental delays. Key symptoms not reported include episodic symptoms or organ dysfunction.
+5 Neurodegenerative disorders (e.g., spinal muscular atrophy): This could explain hypotonia and motor delays. Key symptoms not reported include progressive weakness or muscle wasting.",Hereditary metabolic disorders
"['Methylmalonic acidemia with homocystinuria, type cblC']","+1 Urea Cycle Disorder: Symptoms include hyperammonemia, developmental delays, and neurological symptoms. Key symptoms not reported include episodic vomiting and lethargy during hyperammonemic crises. 
+2 Organic Acidemia: Symptoms include elevated urinary carboxylic acid and methylmalonic aciduria, along with developmental delays and hypotonia. Key symptoms not reported include metabolic acidosis and failure to thrive. 
+3 Mitochondrial Disorder: Symptoms include optic atrophy, hypotonia, and developmental delays. Key symptoms not reported include exercise intolerance and seizures. 
+4 Congenital Metabolic Disorder: Symptoms include abnormal carnitine levels and hypotonia. Key symptoms not reported include hypoglycemia and cardiomyopathy. 
+5 Chromosomal Abnormality or Syndrome: Symptoms include congenital defects and early mortality. Key symptoms not reported include dysmorphic features or specific developmental milestones.",Hereditary metabolic disorders
['Medium chain acyl-CoA dehydrogenase deficiency'],"+1 Fatty Acid Oxidation Disorder: Hypoglycemia, vomiting, diarrhea, elevated hepatic transaminases, abnormal carnitine levels. Key symptoms not reported include specific episodes of metabolic crisis or lethargy.
+2 Glycogen Storage Disease: Hypoglycemia, elevated hepatic transaminases. Key symptoms not reported include hepatomegaly or specific patterns of metabolic derangement.
+3 Urea Cycle Disorder: Elevated hepatic transaminases, vomiting. Key symptoms not reported include hyperammonemia or neurological symptoms.
+4 Organic Acidemia: Vomiting, elevated hepatic transaminases. Key symptoms not reported include metabolic acidosis or specific organic acid profiles.
+5 Mitochondrial Disorder: Vomiting, elevated hepatic transaminases. Key symptoms not reported include exercise intolerance or specific neurological symptoms.",Hereditary metabolic disorders
['Succinic semialdehyde dehydrogenase deficiency'],"+1 Congenital Adrenal Hyperplasia (CAH): Coma, hyperkalemia, hyponatremia, elevated urinary carboxylic acid. Key symptoms not reported: Virilization or ambiguous genitalia in females, adrenal crisis symptoms. 
+2 Urea Cycle Disorder: Coma, neonatal death, elevated urinary carboxylic acid. Key symptoms not reported: Elevated ammonia levels, lethargy, vomiting. 
+3 Severe Respiratory Distress Syndrome (RDS): Coma, respiratory acidosis, neonatal death. Key symptoms not reported: Tachypnea, grunting, retractions. 
+4 Renal Tubular Acidosis (RTA): Hyperkalemia, respiratory acidosis, elevated urinary carboxylic acid. Key symptoms not reported: Growth failure, bone disease, metabolic acidosis. 
+5 Mitochondrial Disorders: Coma, respiratory acidosis, neonatal death. Key symptoms not reported: Muscle weakness, developmental delays, seizures.",Hereditary metabolic disorders
['Homocystinuria due to cystathionine beta-synthase deficiency'],"+1 Homocystinuria: Symptoms consistent include hyperhomocystinemia, hypermethioninemia, ectopia lentis, intellectual disability, motor delay, and ptosis. Key symptoms not reported may include seizures or thromboembolic events. 
+2 Marfan syndrome: Symptoms consistent include ectopia lentis, large hands, and long foot. Key symptoms not reported may include cardiovascular issues or scoliosis. 
+3 Ehlers-Danlos syndrome: Symptoms consistent include large hands and possible motor delay. Key symptoms not reported may include skin hyperelasticity or joint hypermobility. 
+4 Klinefelter syndrome: Symptoms consistent include intellectual disability and motor delay. Key symptoms not reported may include gynecomastia or infertility. 
+5 Turner syndrome: Symptoms consistent include motor delay and possible intellectual disability. Key symptoms not reported may include short stature or webbed neck.",Hereditary metabolic disorders
[],"+1 Congenital Hyperinsulinism: Symptoms consistent include hyperinsulinemia, hypoglycemia, seizures, and feeding difficulties. Key symptoms not reported include growth retardation and potential developmental delays. 
+2 Glycogen Storage Disease: Symptoms consistent include hypoglycemia, feeding difficulties, and seizures. Key symptoms not reported include hepatomegaly and muscle weakness. 
+3 Galactosemia: Symptoms consistent include feeding difficulties, hypoglycemia, and seizures. Key symptoms not reported include jaundice and cataracts. 
+4 Congenital Disorders (e.g., Down Syndrome): Symptoms consistent include epicanthus and wide mouth. Key symptoms not reported include characteristic facial features and developmental delays. 
+5 Hemoglobinopathy (e.g., Sickle Cell Disease): Symptoms consistent include abnormal hemoglobin and potential feeding difficulties. Key symptoms not reported include pain crises and splenic sequestration.",Hereditary metabolic disorders
['Propionic acidemia'],"+1 Urea Cycle Disorder: Symptoms include hyperammonemia, intellectual disability, and seizures. Key symptoms not reported include specific metabolic crisis episodes. 
+2 Non-ketotic Hyperglycinemia: Symptoms include hyperglycinemia, seizures, and motor delay. Key symptoms not reported include specific neurological deficits or episodes of lethargy. 
+3 Organic Acidemia: Symptoms include metabolic derangements, seizures, and developmental delays. Key symptoms not reported include specific metabolic crisis episodes or acidosis. 
+4 Carnitine Transport Defect: Symptoms include abnormal carnitine levels, motor delay, and seizures. Key symptoms not reported include specific energy deficiency symptoms or cardiomyopathy. 
+5 Mitochondrial Disorder: Symptoms include neurological symptoms, metabolic derangements, and early mortality. Key symptoms not reported include exercise intolerance or specific myopathic symptoms.",Hereditary metabolic disorders
['Vitamin B12-unresponsive methylmalonic acidemia'],"+1 Methylmalonic acidemia (MMA): Symptoms include metabolic acidosis, feeding difficulties, hypotonia, and methylmalonic aciduria. Key symptoms not reported include developmental delays or neurological deficits that may develop later.
+2 Propionic acidemia: Symptoms include metabolic acidosis, hypotonia, and feeding difficulties. Key symptoms not reported include specific neurological symptoms or seizures.
+3 Urea cycle disorder: Symptoms include metabolic acidosis and neurological symptoms. Key symptoms not reported include hyperammonemia and specific neurological deficits.
+4 Other organic acidemias: Symptoms may overlap with MMA and include metabolic acidosis and hypotonia. Key symptoms not reported include specific organic acid profiles in urine.
+5 Fatty acid oxidation disorders: Symptoms include hypotonia and metabolic acidosis. Key symptoms not reported include hypoglycemia and specific fatty acid profiles in blood tests.",Hereditary metabolic disorders
['Systemic primary carnitine deficiency'],"+1 Medium-Chain Acyl-CoA Dehydrogenase Deficiency: Hypoglycemia, decreased plasma free carnitine, vomiting. Key symptoms not reported: Fatty acid accumulation in the blood.
+2 Ornithine Transcarbamylase Deficiency: Abnormal circulating amino acid concentrations, potential for sudden death. Key symptoms not reported: Hyperammonemia, neurological symptoms.
+3 Pyruvate Dehydrogenase Deficiency: Coma, increased circulating lactate dehydrogenase concentration. Key symptoms not reported: Elevated lactate levels.
+4 Von Gierke Disease: Hypoglycemia, vomiting, elevated lactate. Key symptoms not reported: Hepatomegaly, hyperlipidemia.
+5 Maple Syrup Urine Disease: Abnormal circulating amino acid concentrations. Key symptoms not reported: Characteristic sweet-smelling urine, neurological decline.",Hereditary metabolic disorders
['3-methylcrotonyl-CoA carboxylase deficiency'],"+1 Primary Carnitine Deficiency: Symptoms include lethargy, poor coordination, and feeding difficulties. Key symptoms not reported include muscle weakness and hypoglycemia. 
+2 Medium-Chain Acyl-CoA Dehydrogenase Deficiency: Symptoms include lethargy, clumsiness, and poor coordination. Key symptoms not reported include hypoglycemia during fasting. 
+3 Mitochondrial Myopathy: Symptoms include poor coordination and lethargy. Key symptoms not reported include muscle weakness and exercise intolerance. 
+4 Urea Cycle Disorder: Symptoms include lethargy and neurological issues. Key symptoms not reported include hyperammonemia and vomiting. 
+5 Organic Acidemia: Symptoms include lethargy and feeding difficulties. Key symptoms not reported include metabolic acidosis and developmental delays.",Hereditary metabolic disorders
[],"+1 Mitochondrial Myopathy: Symptoms consistent include spastic diplegia, spastic tetraplegia, dysarthria, and encephalopathy. Key symptoms not reported may include exercise intolerance and muscle weakness. 
+2 Glycine Encephalopathy (Non-ketotic Hyperglycinemia): Symptoms consistent include abnormal circulating glycine concentration and encephalopathy. Key symptoms not reported may include seizures and hypotonia. 
+3 Ethylmalonic Aciduria: Symptoms consistent include ethylmalonic aciduria and recurrent viral infections. Key symptoms not reported may include developmental delay and metabolic crises. 
+4 Spastic Paraplegia Type 11: Symptoms consistent include spastic diplegia and hyperreflexia. Key symptoms not reported may include progressive weakness and gait abnormalities. 
+5 Leigh Syndrome: Symptoms consistent include encephalopathy, spasticity, and recurrent infections. Key symptoms not reported may include ataxia and respiratory distress.",Hereditary metabolic disorders
['Medium chain acyl-CoA dehydrogenase deficiency'],"+1 Congenital metabolic disorder: This includes conditions like medium-chain acyl-CoA dehydrogenase deficiency (MCADD). Symptoms consistent with this diagnosis include abnormal circulating carnitine concentration and death in infancy. Key symptoms not reported may include hypoglycemia or lethargy prior to death.

+2 Carnitine deficiency: This condition can lead to severe metabolic crises in infants. Symptoms consistent with this diagnosis include abnormal circulating carnitine concentration and death in infancy. Key symptoms not reported may include muscle weakness or cardiomyopathy.

+3 Congenital heart defect: This can lead to significant issues in the neonatal period. Symptoms consistent with this diagnosis include death in infancy and abnormality of prenatal development. Key symptoms not reported may include cyanosis or difficulty breathing.

+4 Genetic syndrome: Certain genetic syndromes can lead to both developmental abnormalities and early mortality. Symptoms consistent with this diagnosis include abnormality of prenatal development and death in infancy. Key symptoms not reported may include specific dysmorphic features or developmental delays.

+5 Neonatal sepsis: This can lead to rapid deterioration and death in infants. Symptoms consistent with this diagnosis include death in infancy. Key symptoms not reported may include fever, irritability, or feeding difficulties.",Hereditary metabolic disorders
['Glutaryl-CoA dehydrogenase deficiency'],"+1 Glutaric Aciduria Type I: Symptoms consistent include elevated circulating glutaric acid concentration, metabolic acidosis, lethargy, hypotonia, and dystonia. Key symptoms not reported include seizures and developmental delays.
+2 Congenital Disorders of Glycosylation: Symptoms consistent include macrocephaly, hypotonia, and lethargy. Key symptoms not reported include failure to thrive and specific facial dysmorphisms.
+3 Mitochondrial Myopathy: Symptoms consistent include generalized hypotonia, lethargy, and metabolic acidosis. Key symptoms not reported include exercise intolerance and muscle weakness.
+4 Krabbe Disease: Symptoms consistent include hypotonia, lethargy, and dystonia. Key symptoms not reported include irritability and developmental regression.
+5 Niemann-Pick Disease: Symptoms consistent include macrocephaly, lethargy, and hypotonia. Key symptoms not reported include hepatosplenomegaly and cherry-red spot on the retina.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Phenylketonuria (PKU): Consistent symptoms include hyperphenylalaninemia and potential developmental issues. Key symptoms not reported include neurological impairment if untreated.
+2 Tyrosinemia: Consistent symptoms include hypertyrosinemia and potential for early mortality. Key symptoms not reported include liver dysfunction and renal issues.
+3 Maple Syrup Urine Disease (MSUD): Consistent symptoms include abnormal development and potential for early death. Key symptoms not reported include specific metabolic crisis episodes and characteristic urine odor.
+4 Urea Cycle Disorders: Consistent symptoms include potential for early mortality and developmental issues. Key symptoms not reported include hyperammonemia and specific neurological symptoms.
+5 Congenital Disorders of Glycosylation: Consistent symptoms include developmental abnormalities and early mortality. Key symptoms not reported include a wide range of systemic symptoms affecting multiple organ systems.",Hereditary metabolic disorders
['L-2-hydroxyglutaric aciduria'],"+1: Leukodystrophy: Symptoms consistent include abnormal cerebral white matter morphology, intellectual disability, and difficulty walking. Key symptoms not reported may include seizures or progressive neurological decline.
+2: Krabbe disease: Symptoms consistent include delayed speech and language development, intellectual disability, hyperreflexia, and difficulty walking. Key symptoms not reported may include irritability and loss of previously acquired skills.
+3: Pelizaeus-Merzbacher disease: Symptoms consistent include intellectual disability, hyperreflexia, and abnormal cerebral white matter morphology. Key symptoms not reported may include nystagmus and spasticity.
+4: Cerebral palsy: Symptoms consistent include difficulty walking, difficulty climbing stairs, and hyperreflexia. Key symptoms not reported may include muscle tone abnormalities and specific motor skill delays.
+5: Rett syndrome: Symptoms consistent include delayed speech and language development, intellectual disability, and difficulty walking. Key symptoms not reported may include hand-wringing movements and loss of purposeful hand skills.",Hereditary metabolic disorders
['Maple syrup urine disease'],"+1 Maple Syrup Urine Disease (MSUD): Symptoms consistent include hypervalinemia and hyperleucinemia. Key symptoms not reported include characteristic sweet-smelling urine and neurological decline during metabolic crises.
+2 Urea Cycle Disorders: Symptoms consistent include hypoglycemia and potential neurological symptoms. Key symptoms not reported include hyperammonemia and specific metabolic crises.
+3 Spinal Muscular Atrophy (SMA): Symptoms consistent include generalized hypotonia and spasticity. Key symptoms not reported include progressive muscle weakness and atrophy.
+4 Glycogen Storage Diseases: Symptoms consistent include hypoglycemia and obesity. Key symptoms not reported include hepatomegaly and exercise intolerance.
+5 Phenylketonuria (PKU): Symptoms consistent include metabolic abnormalities. Key symptoms not reported include intellectual disability and developmental delays if untreated.",Hereditary metabolic disorders
['Classic galactosemia'],"+1 Galactosemia: This diagnosis is consistent with hypergalactosemia and abnormality of galactoside metabolism. Key symptoms not reported include jaundice and failure to thrive in infancy.
+2 Maple Syrup Urine Disease (MSUD): This fits with aminoaciduria and abnormal circulating amino acid concentrations. Key symptoms not reported include neurological symptoms and characteristic urine odor.
+3 Urea Cycle Disorder: This could explain hyperalaninemia and developmental delays. Key symptoms not reported include acute metabolic crises and hyperammonemia.
+4 Tyrosinemia: This aligns with abnormal circulating tyrosine concentration. Key symptoms not reported include liver dysfunction and renal issues.
+5 Fatty Acid Oxidation Disorder: This could explain obesity and metabolic derangements. Key symptoms not reported include hypoglycemia and muscle weakness.",Hereditary metabolic disorders
['3-hydroxy-3-methylglutaric aciduria'],"+1 Urea Cycle Disorder: Hyperammonemia, metabolic acidosis, vomiting. Key symptoms not reported: Neurological symptoms (e.g., lethargy, seizures).
+2 Organic Acidemia (3-Methylglutaconic Aciduria): 3-Methylglutaric aciduria, metabolic acidosis, vomiting. Key symptoms not reported: Developmental delay, hypotonia.
+3 Fatty Acid Oxidation Disorder: Dicarboxylic aciduria, metabolic acidosis, vomiting. Key symptoms not reported: Hypoglycemia, cardiomyopathy.
+4 Glycine Encephalopathy: Abnormal circulating glycine concentration, vomiting. Key symptoms not reported: Neurological symptoms (e.g., seizures, developmental delay).
+5 Mitochondrial Disorder: Metabolic acidosis, hyperammonemia, vomiting. Key symptoms not reported: Muscle weakness, exercise intolerance.",Hereditary metabolic disorders
['Homocystinuria due to cystathionine beta-synthase deficiency'],"+1 Homocystinuria: This condition is consistent with hyperhomocystinemia, progressive neurologic deterioration, and hypotonia. Key symptoms not reported include lens dislocation and skeletal abnormalities. 
+2 Methionine adenosyltransferase deficiency: Fits with hypomethioninemia and neurological symptoms. Key symptoms not reported include liver dysfunction signs and developmental delays. 
+3 Porphyria: The abnormal circulating porphyrin concentration aligns with this diagnosis, along with neurological symptoms. Key symptoms not reported include photosensitivity and abdominal pain. 
+4 Urea cycle disorder: Could explain neurological deterioration and metabolic issues. Key symptoms not reported include hyperammonemia and specific metabolic crises. 
+5 Combined immunodeficiency: The recurrent viral infections and neurological decline suggest this possibility. Key symptoms not reported include failure to thrive and opportunistic infections.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Phenylketonuria (PKU): Symptoms consistent include hyperphenylalaninemia and developmental issues. Key symptoms not reported include neurological deficits and intellectual disability.
+2 Tyrosinemia: Symptoms consistent include hypertyrosinemia and potential for early mortality. Key symptoms not reported include liver dysfunction and renal issues.
+3 Congenital Disorders of Glycosylation (CDG): Symptoms consistent include abnormalities of prenatal development and early mortality. Key symptoms not reported include specific developmental delays and organ dysfunction.
+4 Cystic Fibrosis: Symptoms consistent include chronic pulmonary obstruction. Key symptoms not reported include recurrent respiratory infections and digestive issues.
+5 Severe Combined Immunodeficiency (SCID): Symptoms consistent include early mortality and developmental issues. Key symptoms not reported include recurrent infections and failure to thrive.",Hereditary metabolic disorders
['Biotinidase deficiency'],"+1 Organic Acidemia: Elevated urinary carboxylic acid, seizures, spasticity. Key symptoms not reported: Specific metabolic derangements or acidosis symptoms. 
+2 Krabbe Disease: Seizures, spasticity, death in infancy. Key symptoms not reported: Developmental delays or specific sensory deficits. 
+3 Adrenoleukodystrophy (ALD): Seizures, spasticity, death in infancy, alopecia. Key symptoms not reported: Behavioral changes or adrenal insufficiency symptoms. 
+4 Urea Cycle Disorder: Elevated urinary carboxylic acid, seizures, fatigue. Key symptoms not reported: Hyperammonemia symptoms such as vomiting or lethargy. 
+5 Mitochondrial Disorder: Seizures, dyspnea, fatigue. Key symptoms not reported: Muscle weakness or exercise intolerance.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Phenylketonuria (PKU): This condition is characterized by hyperphenylalaninemia, which aligns with the patient's symptoms. Key symptoms not reported include intellectual disability if untreated. 
+2 Tyrosinemia (Type I): Hypertyrosinemia is a hallmark of this condition, and the gastrointestinal inflammation and recurrent fevers could indicate metabolic crises. Symptoms not reported include liver dysfunction and renal issues. 
+3 Maple Syrup Urine Disease: This disorder can present with vomiting and metabolic crises, but it typically does not cause obesity. Key symptoms not reported include characteristic sweet-smelling urine and neurological symptoms. 
+4 Urea Cycle Disorder: This could explain the vomiting and metabolic disturbances, but obesity is less common. Symptoms not reported include hyperammonemia and neurological symptoms. 
+5 Mitochondrial Disorder: These can present with a variety of symptoms including obesity and metabolic crises, but the specific metabolic abnormalities suggest a more targeted disorder. Symptoms not reported include exercise intolerance and muscle weakness.",Hereditary metabolic disorders
['Biotinidase deficiency'],"+1 Non-ketotic hyperglycinemia: This condition is characterized by elevated glycine levels, aminoaciduria, and neurological symptoms. The patient's increased CSF lactate and metabolic acidosis are consistent with this diagnosis. Key symptoms not reported include seizures or developmental delays.

+2 Mitochondrial disorder: The combination of metabolic acidosis and increased CSF lactate suggests a mitochondrial dysfunction. The patient's skin rash may also be related to mitochondrial involvement. Key symptoms not reported include muscle weakness or exercise intolerance.

+3 Maple syrup urine disease: This disorder can present with metabolic acidosis and aminoaciduria. However, the specific elevation of glycine and the type of skin rash are less typical. Key symptoms not reported include characteristic sweet-smelling urine and neurological symptoms.

+4 Urea cycle disorder: This could explain metabolic acidosis and aminoaciduria, but the specific elevation of glycine and the skin rash are less consistent. Key symptoms not reported include hyperammonemia and associated neurological symptoms.

+5 Phenylketonuria (PKU): While this condition involves aminoaciduria and can lead to neurological issues, the specific symptoms of increased CSF lactate and the type of skin rash are not typical. Key symptoms not reported include intellectual disability and musty odor in urine.",Hereditary metabolic disorders
['Vitamin B12-unresponsive methylmalonic acidemia'],"+1 Methylmalonic acidemia (MMA): This condition is consistent with decreased methylmalonyl-CoA mutase activity, feeding difficulties, dehydration, and neonatal death. Key symptoms not reported include developmental delays and metabolic crises.
+2 Propionic acidemia: This condition could explain feeding difficulties and dehydration but is less likely due to the specific enzyme deficiency noted. Key symptoms not reported include metabolic acidosis and lethargy.
+3 Organic acidemia: This is a broader category that could encompass MMA and other conditions but is too vague to be a primary diagnosis. Key symptoms not reported vary widely depending on the specific type.
+4 Urea cycle disorders: While they can present with similar symptoms, the specific enzyme deficiency does not align with these disorders. Key symptoms not reported include hyperammonemia and neurological symptoms.
+5 Other metabolic disorders: This is a catch-all category that could include various conditions but lacks specificity. Key symptoms not reported would depend on the specific disorder considered.",Hereditary metabolic disorders
['Biotinidase deficiency'],"+1 Propionic Acidemia: Symptoms consistent include increased circulating lactate concentration, decreased pyruvate carboxylase activity, propionyl-CoA carboxylase deficiency, elevated urinary carboxylic acid, and generalized hypotonia. Key symptoms not reported include specific neurological deficits or cardiomyopathy.

+2 Mitochondrial Myopathy: Symptoms consistent include lethargy, fatigue, and generalized hypotonia. Key symptoms not reported include exercise intolerance and muscle weakness.

+3 Maple Syrup Urine Disease: Symptoms consistent include aminoaciduria and lethargy. Key symptoms not reported include characteristic sweet-smelling urine and neurological symptoms.

+4 Urea Cycle Disorder: Symptoms consistent include metabolic acidosis and lethargy. Key symptoms not reported include hyperammonemia and specific neurological symptoms.

+5 Glycine Encephalopathy: Symptoms consistent include abnormal circulating glycine concentration and lethargy. Key symptoms not reported include seizures and specific developmental delays.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Tyrosinemia Type I: This condition is characterized by hypertyrosinemia and can lead to severe complications, including death in infancy and childhood. 
+2 Phenylketonuria (PKU): Characterized by hyperphenylalaninemia, which can lead to severe neurological issues if untreated, but does not typically cause death unless complications arise. 
+3 Maple Syrup Urine Disease (MSUD): While it can cause severe neurological damage and death in infancy, it does not correlate with the reported amino acid abnormalities. 
+4 Urea Cycle Disorders: These can lead to fatal outcomes in infancy but do not align with the specific amino acid abnormalities reported. 
+5 Congenital Disorders of Glycosylation: Can cause developmental issues and metabolic disturbances, but the specific amino acid abnormalities do not typically align with this diagnosis.",Hereditary metabolic disorders
['3-hydroxy-3-methylglutaric aciduria'],"+1 Medium-chain acyl-CoA dehydrogenase deficiency (MCADD): This condition is consistent with dicarboxylic aciduria and can lead to death in infancy. Key symptoms not reported include hypoglycemia and lethargy during metabolic crises. 
+2 3-Hydroxy-3-methylglutaryl-CoA lyase deficiency: This condition aligns with 3-methylglutaric aciduria and can cause severe metabolic issues in infancy. Key symptoms not reported include vomiting and metabolic acidosis during crises. 
+3 Isovaleric acidemia: This organic acidemia can present with elevated urinary carboxylic acids and may lead to severe symptoms in infancy. Key symptoms not reported include a characteristic ""sweaty feet"" odor and metabolic crises. 
+4 Propionic acidemia: This condition can also present with elevated urinary carboxylic acids and severe infantile symptoms. Key symptoms not reported include vomiting, hypotonia, and metabolic acidosis. 
+5 Glutaric aciduria type I: This condition can present with dicarboxylic aciduria and may lead to neurological symptoms. Key symptoms not reported include movement disorders and macrocephaly.",Hereditary metabolic disorders
['Wilson disease'],"+1 Wilson's disease: This condition is characterized by decreased ceruloplasmin, increased urinary copper, and liver dysfunction. The patient’s symptoms of elevated hepatic transaminases and abnormal copper metabolism strongly support this diagnosis. Key symptoms not reported include neurological symptoms or Kayser-Fleischer rings.

+2 Hemochromatosis: This condition could explain the decreased iron concentration and liver dysfunction. The obesity and liver enzyme elevation may also fit. However, the copper metabolism abnormalities make this less likely. Key symptoms not reported include skin changes (bronzing) and diabetes.

+3 Urea cycle disorder: The abnormal amino acid concentrations could suggest a urea cycle disorder, which can lead to elevated ammonia levels and neurological symptoms. However, the copper metabolism issues are not typical for this condition. Key symptoms not reported include hyperammonemia and neurological deficits.

+4 Porphyria: The abnormal porphyrin levels suggest a possible porphyria, which can cause liver dysfunction and neurological symptoms. However, the copper metabolism abnormalities are not typical for porphyria. Key symptoms not reported include photosensitivity and abdominal pain.

+5 Metabolic syndrome: The combination of obesity and liver dysfunction could suggest metabolic syndrome, which can lead to non-alcoholic fatty liver disease. However, the specific copper and amino acid abnormalities make this less likely. Key symptoms not reported include insulin resistance and hypertension.",Hereditary metabolic disorders
['Medium chain acyl-CoA dehydrogenase deficiency'],"+1 Carnitine Palmitoyltransferase I Deficiency: This condition is consistent with the abnormal circulating carnitine concentration and can lead to death in infancy. Key symptoms not reported include hypoketotic hypoglycemia and muscle weakness.
+2 Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCADD): This diagnosis aligns with the metabolic issues indicated by the abnormal carnitine levels and can result in neonatal death. Key symptoms not reported include episodes of hypoglycemia and lethargy.
+3 Congenital Heart Defects: This condition can lead to death in infancy and is associated with prenatal developmental abnormalities. Key symptoms not reported include cyanosis and difficulty breathing.
+4 Mitochondrial Disorders: These can present with metabolic issues and developmental abnormalities, leading to neonatal death. Key symptoms not reported include developmental delays and muscle weakness.
+5 Urea Cycle Disorders: These can cause severe metabolic disturbances and lead to death in infancy. Key symptoms not reported include vomiting, lethargy, and altered mental status.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Tyrosinemia: This condition is characterized by hypertyrosinemia and can lead to liver dysfunction and increased susceptibility to infections. The recurrent viral infections and early mortality align with severe forms of this disorder. Key symptoms not reported include liver failure and neurological symptoms. 
+2 Phenylketonuria (PKU): This condition leads to hyperphenylalaninemia. While it typically does not cause recurrent infections, if untreated, it can lead to severe neurological damage and early death. Key symptoms not reported include developmental delays and intellectual disability. 
+3 Urea cycle disorder: These disorders can lead to metabolic crises and recurrent infections due to metabolic derangements. However, the specific metabolic markers do not align perfectly. Key symptoms not reported include hyperammonemia and neurological symptoms during metabolic crises. 
+4 Severe combined immunodeficiency (SCID): This condition could explain the recurrent viral infections and early mortality. However, it does not directly explain the metabolic abnormalities. Key symptoms not reported include failure to thrive and absence of lymphoid tissue. 
+5 Metabolic syndrome with immune dysfunction: This broader category could encompass several metabolic disorders leading to immune dysfunction, but it is less specific. Key symptoms not reported include obesity, insulin resistance, and other metabolic derangements.",Hereditary metabolic disorders
['3-methylcrotonyl-CoA carboxylase deficiency'],"+1 Non-ketotic hyperglycinemia (NKH): This diagnosis is supported by the abnormal circulating glycine concentration and aminoaciduria. Key symptoms not reported include neurological symptoms such as seizures or developmental delays. 
+2 Primary carnitine deficiency: The abnormal circulating carnitine concentration aligns with this diagnosis, along with elevated urinary carboxylic acid. Key symptoms not reported include muscle weakness or cardiomyopathy. 
+3 Organic acidemia (e.g., propionic acidemia or methylmalonic acidemia): Elevated urinary carboxylic acid and aminoaciduria support this diagnosis. Key symptoms not reported include metabolic acidosis or failure to thrive. 
+4 Glycine encephalopathy: Elevated glycine levels are consistent with this diagnosis, but the absence of neurological symptoms makes it less likely. Key symptoms not reported include severe neurological impairment. 
+5 Urea cycle disorder: Aminoaciduria is consistent with this diagnosis, but the specific abnormalities in glycine and carnitine concentrations may not fit. Key symptoms not reported include hyperammonemia or altered mental status.",Hereditary metabolic disorders
['Carbamoyl-phosphate synthetase 1 deficiency'],"+1 Mitochondrial disorder: This condition is consistent with generalized hypotonia, hepatomegaly, and 3-methylglutaconic aciduria. Key symptoms not reported may include developmental delays or seizures. 
+2 Organic acidemia: The presence of 3-methylglutaconic aciduria aligns with this diagnosis, along with hypotonia and feeding difficulties. Key symptoms not reported may include metabolic acidosis or failure to thrive. 
+3 Lysosomal storage disorder: This could explain hepatomegaly and hypotonia. Key symptoms not reported may include skeletal abnormalities or neurological decline. 
+4 Urea cycle disorder: While feeding difficulties and hypotonia are present, the specific metabolic profile makes this less likely. Key symptoms not reported may include hyperammonemia or altered mental status. 
+5 Peroxisomal disorder: This could present with hypotonia and hepatomegaly. Key symptoms not reported may include neurological deficits or vision problems.",Hereditary metabolic disorders
['Citrullinemia type I'],"+1 Urea Cycle Disorder (e.g., Ornithine Transcarbamylase Deficiency): Symptoms include hyperammonemia, orotic aciduria, lethargy, and motor delay. Key symptoms not reported include seizures or neurological deficits. 
+2 Maple Syrup Urine Disease: Symptoms include lethargy, hypoglycemia, and elevated plasma amino acids. Key symptoms not reported include a characteristic sweet odor in urine and neurological symptoms. 
+3 Mitochondrial Disorder: Symptoms include lethargy, motor delay, and respiratory alkalosis. Key symptoms not reported include exercise intolerance and muscle weakness. 
+4 Fatty Acid Oxidation Disorder: Symptoms include hypoglycemia, lethargy, and obesity. Key symptoms not reported include cardiomyopathy and episodes of metabolic crisis. 
+5 Genetic Syndrome (e.g., Prader-Willi Syndrome): Symptoms include obesity, motor delay, and lethargy. Key symptoms not reported include hyperphagia and behavioral issues.",Hereditary metabolic disorders
['Glutaryl-CoA dehydrogenase deficiency'],"+1 Glutaric Aciduria Type I: This condition is consistent with the patient's history of glutaric aciduria, seizures, hypotonia, and macrocephaly. Key symptoms not reported include developmental delays and specific metabolic crises. 
+2 Cerebral Palsy: The presence of generalized hypotonia and athetosis aligns with this diagnosis, although the metabolic aspect makes it less likely as the primary condition. Key symptoms not reported include spasticity or other movement disorders. 
+3 Metachromatic Leukodystrophy: This could explain the neurological symptoms and seizures, but macrocephaly is less common. Key symptoms not reported include cognitive decline and specific motor deficits. 
+4 Bardet-Biedl Syndrome: This syndrome could explain macrocephaly and visual issues, but lacks other systemic features. Key symptoms not reported include obesity and renal anomalies. 
+5 Aicardi Syndrome: The combination of macrocephaly and seizures could fit, but the absence of corpus callosum agenesis makes it less likely. Key symptoms not reported include chorioretinal lacunae and developmental delays.",Hereditary metabolic disorders
['Tyrosinemia type 1'],"+1 Tyrosinemia Type I: Symptoms consistent include hypertyrosinemia, delayed speech and language development, and potential neurological involvement. Key symptoms not reported include liver dysfunction and failure, which may not be evident until later stages. 
+2 Phenylketonuria (PKU): Symptoms consistent include abnormal circulating phenylalanine concentration and delayed speech and language development. Key symptoms not reported include intellectual disability and seizures, which may develop if untreated. 
+3 Alkaptonuria: Symptoms consistent include elevated urinary metabolites, though the primary symptoms of this condition (dark urine, arthritis) are not reported. 
+4 Maple Syrup Urine Disease: Symptoms consistent include delayed development and potential neurological issues. Key symptoms not reported include characteristic sweet-smelling urine and specific amino acid imbalances. 
+5 Uroporphyria: Symptoms consistent include elevated delta-aminolevulinic acid. Key symptoms not reported include photosensitivity and abdominal pain, which may not be present in all cases.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Tyrosinemia: This condition is characterized by elevated levels of tyrosine in the blood and urine, which aligns with the patient's hypertyrosinemia and elevated urinary carboxylic acid. Key symptoms not reported include liver dysfunction and renal issues. 

+2 Phenylketonuria (PKU): The presence of hyperphenylalaninemia suggests PKU, which can lead to severe neurological impairment if untreated. Symptoms not reported include developmental delays and intellectual disability.

+3 Maple Syrup Urine Disease (MSUD): This disorder can present with elevated branched-chain amino acids and may lead to severe metabolic crises. Symptoms not reported include characteristic sweet-smelling urine and neurological symptoms.

+4 Organic Acidemia: The elevated urinary carboxylic acid could indicate an organic acidemia, which can lead to metabolic acidosis and neurological symptoms. Symptoms not reported include vomiting and lethargy during metabolic crises.

+5 Urea Cycle Disorder: This condition can lead to hyperammonemia and may present with similar symptoms. Symptoms not reported include confusion, seizures, and respiratory distress during metabolic decompensation.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Tyrosinemia: This condition is consistent with hypertyrosinemia and can lead to seizures and intellectual disability. Key symptoms not reported include liver dysfunction and potential renal issues.
+2 Phenylketonuria (PKU): Hyperphenylalaninemia aligns with this diagnosis, and it can cause intellectual disability and seizures. However, obesity and severe short stature are not typical features.
+3 Maple Syrup Urine Disease (MSUD): Elevated urinary carboxylic acid levels and seizures are consistent with this condition. Key symptoms not reported include a characteristic sweet odor in urine and feeding difficulties in infancy.
+4 Prader-Willi Syndrome: This syndrome matches the obesity and intellectual disability, but it does not typically present with the metabolic abnormalities noted. Key symptoms not reported include hypogonadism and behavioral issues.
+5 Urea Cycle Disorders: These can lead to neurological symptoms and metabolic crises, but the specific metabolic markers do not align with this group. Key symptoms not reported include hyperammonemia and respiratory distress.",Hereditary metabolic disorders
['Vitamin B12-unresponsive methylmalonic acidemia'],"+1 Methylmalonic Acidemia (MMA): Symptoms consistent include metabolic acidosis, hyperammonemia, and methylmalonic aciduria. Key symptoms not reported include developmental delays or failure to thrive.

+2 Urea Cycle Disorder: Symptoms consistent include hyperammonemia and metabolic acidosis. Key symptoms not reported include specific neurological deficits or episodic crises.

+3 Organic Acidemia: Symptoms consistent include metabolic acidosis and hyperammonemia. Key symptoms not reported include specific organic acid profiles in urine.

+4 Severe Combined Immunodeficiency (SCID): Symptoms consistent include leukopenia and thrombocytopenia. Key symptoms not reported include recurrent infections or failure to thrive.

+5 Congenital Hypopituitarism: Symptoms consistent include generalized hypotonia. Key symptoms not reported include growth failure or specific hormonal deficiencies.",Hereditary metabolic disorders
['Medium chain acyl-CoA dehydrogenase deficiency'],"+1 Inborn Errors of Metabolism: This includes conditions like fatty acid oxidation disorders. Symptoms consistent with this diagnosis include abnormal circulating carnitine concentration and death in infancy. Key symptoms not reported may include hypoglycemia or lethargy prior to death.

+2 Congenital Heart Defects: These can lead to death in infancy and may be associated with prenatal development issues. Symptoms consistent with this diagnosis include death in infancy and abnormality of prenatal development. Key symptoms not reported may include cyanosis or difficulty breathing.

+3 Genetic Syndromes: Conditions such as Zellweger syndrome could explain the combination of symptoms. Symptoms consistent with this diagnosis include abnormality of prenatal development and death in infancy. Key symptoms not reported may include hypotonia or seizures.

+4 Maternal Factors: Conditions like maternal diabetes could lead to the observed symptoms. Symptoms consistent with this diagnosis include abnormality of prenatal development and neonatal death. Key symptoms not reported may include maternal health history or complications during pregnancy.

+5 Metabolic Disorders: Other metabolic disorders beyond fatty acid oxidation could also be considered. Symptoms consistent with this diagnosis include abnormal circulating carnitine concentration and death in infancy. Key symptoms not reported may include failure to thrive or feeding difficulties.",Hereditary metabolic disorders
['Vitamin B12-unresponsive methylmalonic acidemia'],"+1 Methylmalonic acidemia: Symptoms consistent include methylmalonic aciduria, hyperammonemia, and metabolic acidosis. Key symptoms not reported may include neurological symptoms or developmental delays.
+2 Propionic acidemia: Symptoms consistent include metabolic acidosis and hyperammonemia. Key symptoms not reported may include hypoglycemia or cardiomyopathy.
+3 Urea cycle disorder: Symptoms consistent include hyperammonemia and metabolic acidosis. Key symptoms not reported may include lethargy or seizures.
+4 Organic acidemia: Symptoms consistent include metabolic acidosis and vomiting. Key symptoms not reported may include failure to thrive or developmental delays.
+5 Vitamin B12 deficiency: Symptoms consistent include methylmalonic aciduria. Key symptoms not reported may include anemia or neurological symptoms.",Hereditary metabolic disorders
['Ornithine transcarbamylase deficiency'],"+1 Ornithine transcarbamylase deficiency: Hyperammonemia, seizures, cerebral edema. Key symptoms not reported: Orotic aciduria is typically absent. 
+2 Argininosuccinic aciduria: Hyperammonemia, seizures, orotic aciduria. Key symptoms not reported: May have specific neurological deficits or developmental delays. 
+3 Carbamoyl phosphate synthetase I deficiency: Hyperammonemia, seizures. Key symptoms not reported: Orotic aciduria is typically absent. 
+4 Citrullinemia: Hyperammonemia, seizures. Key symptoms not reported: Orotic aciduria is typically absent. 
+5 Urea cycle disorder (general): Hyperammonemia, seizures, cerebral edema. Key symptoms not reported: Specific enzyme deficiencies would need to be identified.",Hereditary metabolic disorders
['Biotinidase deficiency'],"+1 Organic acidemia: This diagnosis is consistent with elevated urinary carboxylic acid, seizures, and hypotonia. Key symptoms not reported include metabolic acidosis or specific metabolic crises.
+2 Spinal muscular atrophy (SMA): This condition aligns with generalized hypotonia and fasciculations. Key symptoms not reported include progressive muscle weakness and respiratory difficulties.
+3 Mitochondrial disorder: This could explain seizures, hypotonia, and growth delay. Key symptoms not reported include exercise intolerance and lactic acidosis.
+4 Urea cycle disorder: This could account for neurological symptoms and growth delay. Key symptoms not reported include hyperammonemia and specific metabolic derangements.
+5 Krabbe disease: This lysosomal storage disorder could explain hypotonia, seizures, and growth delay. Key symptoms not reported include irritability and developmental regression.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Phenylketonuria (PKU): This condition is characterized by hyperphenylalaninemia. The patient’s obesity is atypical for PKU, which usually leads to neurological issues if untreated. 
+2 Tyrosinemia: This condition leads to hypertyrosinemia and can cause severe liver issues, potentially explaining early mortality. Obesity is not a typical feature, but metabolic derangements could contribute to weight gain.
+3 Metabolic syndrome: This could explain obesity and hypercholesterolemia, but does not account for the specific amino acid abnormalities. 
+4 Urea cycle disorder: This could lead to metabolic derangements, but the specific amino acid elevations do not align perfectly with this diagnosis. 
+5 Genetic metabolic disorder: Other genetic syndromes could be considered, but they typically have distinct presentations. The combination of symptoms suggests a complex metabolic issue.",Hereditary metabolic disorders
['Phenylketonuria'],"+1: Tyrosinemia: The patient has hypertyrosinemia, which is consistent with this diagnosis. Key symptoms not reported include liver dysfunction and potential neurological issues.
+2: Phenylketonuria (PKU): The presence of hyperphenylalaninemia aligns with this diagnosis. Key symptoms not reported include developmental delays and intellectual disability.
+3: Congenital Adrenal Hyperplasia (CAH): Hypospadias and severe short stature are consistent with CAH. Key symptoms not reported include electrolyte imbalances and adrenal crisis.
+4: Genetic Syndromes (e.g., Turner syndrome, Noonan syndrome): Severe short stature and hypospadias could suggest a genetic syndrome. Key symptoms not reported include specific facial features or other congenital anomalies.
+5: Urea Cycle Disorders: While not directly indicated by the symptoms, metabolic issues could suggest this. Key symptoms not reported include lethargy, vomiting, and neurological symptoms.",Hereditary metabolic disorders
['Smith-Lemli-Opitz syndrome'],"+1 Smith-Lemli-Opitz Syndrome: This condition is characterized by microcephaly, low-set ears, wide nasal bridge, strabismus, syndactyly, intellectual disability, and elevated 7-dehydrocholesterol levels. Key symptoms not reported include congenital heart defects and genital anomalies.
+2 Down Syndrome: The presence of microcephaly, low-set ears, and developmental delays could suggest Down syndrome, although the specific features of strabismus and syndactyly are less common. Key symptoms not reported include characteristic facial features and hypotonia.
+3 Cornelia de Lange Syndrome: This syndrome can present with microcephaly, low-set ears, and developmental delays. The presence of syndactyly and severe short stature aligns with this diagnosis. Key symptoms not reported include facial dysmorphism and limb malformations.
+4 Turner Syndrome: While typically associated with females, Turner syndrome can present with short stature and developmental delays. The presence of microcephaly and hearing impairment could fit, but the specific features of syndactyly and strabismus are less common. Key symptoms not reported include ovarian dysgenesis and webbed neck.
+5 Achondroplasia: This condition is characterized by severe short stature and motor delays. While it does not typically present with microcephaly or syndactyly, the combination of developmental delays and short stature could suggest this diagnosis. Key symptoms not reported include characteristic skeletal abnormalities and macrocephaly.",Hereditary metabolic disorders
['Glutaryl-CoA dehydrogenase deficiency'],"+1 Glutaric Aciduria Type I: Symptoms include ataxia, opisthotonus, progressive neurologic deterioration, elevated glutaric acid concentration, and abnormal acylcarnitine concentration. Key symptoms not reported include specific metabolic crises or episodes of metabolic decompensation.

+2 Carnitine Palmitoyltransferase I Deficiency: Symptoms include decreased plasma free carnitine and neurological symptoms. Key symptoms not reported include hypoketotic hypoglycemia and muscle weakness.

+3 Organic Acidemia: Symptoms may include metabolic acidosis and neurological symptoms. Key symptoms not reported include specific organic acid profiles that could differentiate between types.

+4 Urea Cycle Disorder: Symptoms may include hyperammonemia and neurological symptoms. Key symptoms not reported include specific episodes of confusion or lethargy related to ammonia levels.

+5 Mitochondrial Disorder: Symptoms may include myopathy and neurological symptoms. Key symptoms not reported include exercise intolerance or specific mitochondrial dysfunction markers.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Congenital Disorders of Glycine Metabolism: This condition can lead to hypotonia, motor delays, and metabolic abnormalities. The presence of hypertyrosinemia and hyperphenylalaninemia aligns with metabolic dysfunction. Key symptoms not reported include seizures or developmental regression.

+2 Phenylketonuria (PKU): This metabolic disorder is characterized by hyperphenylalaninemia and can lead to developmental delays and hypotonia. The patient’s symptoms of motor delay and hypotonia are consistent. Key symptoms not reported include intellectual disability if untreated.

+3 Tyrosinemia: This condition is associated with hypertyrosinemia and can lead to severe neurological issues and hypotonia. The combination of motor delay and metabolic abnormalities fits well. Key symptoms not reported include liver dysfunction or renal issues.

+4 Prader-Willi Syndrome: This genetic disorder can present with hypotonia, motor delays, and developmental issues. The presence of hip dysplasia may also be relevant. Key symptoms not reported include obesity and hyperphagia.

+5 Spinal Muscular Atrophy (SMA): This condition leads to generalized hypotonia and motor delays due to motor neuron degeneration. The combination of hypotonia and motor delay is consistent. Key symptoms not reported include progressive muscle weakness and respiratory issues.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Metabolic Disorder (e.g., Tyrosinemia): This condition is consistent with hypertyrosinemia and can lead to neurological symptoms, seizures, and hypotonia. Key symptoms not reported include liver dysfunction and potential renal issues. 
+2 Phenylketonuria (PKU): The presence of hyperphenylalaninemia aligns with this diagnosis, which can cause neurological impairment and developmental delays. Key symptoms not reported include intellectual disability and behavioral issues. 
+3 Congenital Disorders (e.g., Smith-Lemli-Opitz syndrome): The combination of retrognathia and hypotonia suggests a congenital syndrome. Key symptoms not reported include cardiac defects and other dysmorphic features. 
+4 Neuromuscular Disorder (e.g., Spinal Muscular Atrophy): Generalized hypotonia and respiratory issues like apnea could indicate a neuromuscular condition. Key symptoms not reported include muscle weakness and atrophy. 
+5 Neurodegenerative Disorder (e.g., Batten Disease): The combination of seizures, hypotonia, and early mortality could suggest a neurodegenerative process. Key symptoms not reported include vision loss and cognitive decline.",Hereditary metabolic disorders
['Tyrosinemia type 1'],"+1: Tyrosinemia type I: Symptoms consistent include elevated circulating tyrosine levels, seizures, and intellectual disability. Key symptoms not reported include liver dysfunction and failure. 
+2: Autism Spectrum Disorder (ASD): Symptoms consistent include autistic behavior, self-mutilation, hyperactivity, and intellectual disability. Key symptoms not reported include social communication deficits and restricted interests. 
+3: Prader-Willi Syndrome: Symptoms consistent include obesity, motor delay, and intellectual disability. Key symptoms not reported include hypogonadism and characteristic facial features. 
+4: Mitochondrial Disorder: Symptoms consistent include seizures, motor delay, and intellectual disability. Key symptoms not reported include exercise intolerance and specific organ dysfunction. 
+5: Urea Cycle Disorder: Symptoms consistent include intellectual disability, seizures, and abnormal amino acid concentrations. Key symptoms not reported include hyperammonemia and acute metabolic crises.",Hereditary metabolic disorders
['Classic galactosemia'],"+1 Galactosemia: This condition is consistent with hypergalactosemia, vomiting, and increased bilirubin levels. Key symptoms not reported include cataracts and developmental delays. 
+2 Crigler-Najjar syndrome: This condition explains increased bilirubin levels and could lead to neonatal death, but does not account for hypergalactosemia. Key symptoms not reported include jaundice and kernicterus. 
+3 Biliary atresia: This could explain increased bilirubin and neonatal death, but does not account for hypergalactosemia. Key symptoms not reported include pale stools and dark urine. 
+4 Galactokinase deficiency: This condition leads to hypergalactosemia and could cause vomiting, but is less severe than classic galactosemia. Key symptoms not reported include cataracts. 
+5 Tyrosinemia: This condition can cause vomiting and increased bilirubin but does not explain hypergalactosemia. Key symptoms not reported include failure to thrive and liver dysfunction.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Phenylketonuria (PKU): Symptoms consistent include hyperphenylalaninemia and abnormal tyrosine concentration. Key symptoms not reported may include developmental delays and neurological issues if untreated. 
+2 Tyrosinemia: Symptoms consistent include abnormal circulating tyrosine concentration and potential for neonatal death. Key symptoms not reported may include liver dysfunction and failure to thrive. 
+3 Maple Syrup Urine Disease (MSUD): Symptoms consistent include abnormal metabolic profiles and potential for severe outcomes in infancy. Key symptoms not reported may include characteristic sweet-smelling urine and neurological symptoms. 
+4 Urea Cycle Disorders: Symptoms consistent include potential for neonatal death and metabolic disturbances. Key symptoms not reported may include hyperammonemia and neurological symptoms. 
+5 Congenital Disorders of Glycosylation: Symptoms consistent include abnormality of prenatal development and potential for severe outcomes. Key symptoms not reported may include developmental delays and multi-organ involvement.",Hereditary metabolic disorders
['Biotinidase deficiency'],"+1 Carnitine Palmitoyltransferase I or II Deficiency: Symptoms consistent include abnormal circulating carnitine concentration and obesity. Key symptoms not reported include episodes of hypoglycemia or metabolic crises.
+2 Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCADD): Symptoms consistent include abnormal circulating carnitine concentration and potential obesity. Key symptoms not reported include severe hypoglycemia or metabolic decompensation episodes.
+3 Mitochondrial Myopathy: Symptoms consistent include obesity and potential metabolic issues. Key symptoms not reported include muscle weakness and exercise intolerance.
+4 Urea Cycle Disorders: Symptoms consistent include abnormal metabolic markers. Key symptoms not reported include hyperammonemia and neurological symptoms.
+5 Glycogen Storage Diseases: Symptoms consistent include obesity and metabolic issues. Key symptoms not reported include hepatomegaly or muscle weakness.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Phenylketonuria (PKU): This condition is consistent with hyperphenylalaninemia and intellectual disability. Key symptoms not reported include a strict dietary requirement to prevent cognitive decline. 
+2 Tyrosinemia: This aligns with hypertyrosinemia and can lead to severe complications, including death in infancy. Key symptoms not reported include liver dysfunction and potential renal issues. 
+3 Maple Syrup Urine Disease (MSUD): This condition can lead to intellectual disability and early mortality. Key symptoms not reported include the characteristic sweet odor of urine and specific metabolic crises. 
+4 Congenital Disorders of Glycosylation (CDG): This could explain the intellectual disability and early mortality. Key symptoms not reported include a wide range of systemic issues and developmental delays. 
+5 Mitochondrial Disorders: These can lead to developmental delays and early mortality. Key symptoms not reported include muscle weakness, seizures, and a variety of systemic symptoms.",Hereditary metabolic disorders
['Smith-Lemli-Opitz syndrome'],"+1 Smith-Lemli-Opitz syndrome: This condition is consistent with the patient's elevated 8-dehydrocholesterol and 7-dehydrocholesterol levels, as well as the presence of cryptorchidism, hypospadias, microcephaly, and developmental delays. Key symptoms not reported include congenital heart defects.

+2 Congenital syndromes (e.g., Turner syndrome): The patient exhibits low-set ears, strabismus, and developmental delays, which can be seen in Turner syndrome. However, the specific combination of symptoms is less typical. Key symptoms not reported include short stature and ovarian dysgenesis.

+3 Zellweger syndrome: This metabolic disorder could explain the neurological symptoms and physical anomalies, including hypotonia and hearing impairment. Key symptoms not reported include liver dysfunction and specific facial dysmorphisms.

+4 Fragile X syndrome: The intellectual disability and developmental delays align with this diagnosis, but the physical features such as cryptorchidism and syndactyly are less common. Key symptoms not reported include macroorchidism and specific facial features.

+5 Down syndrome: The presence of low-set ears and developmental delays could suggest this diagnosis, but the specific combination of symptoms, particularly the metabolic issues, makes it less likely. Key symptoms not reported include characteristic facial features and hypotonia at birth.",Hereditary metabolic disorders
['Canavan disease'],"+1 Prader-Willi Syndrome: This condition is consistent with obesity, hypotonia, and developmental delays. Key symptoms not reported include behavioral issues and hypogonadism. 
+2 Mitochondrial Disorder: This could explain the neurological symptoms, hypotonia, and cerebral atrophy. Key symptoms not reported include exercise intolerance and seizures. 
+3 Spinal Muscular Atrophy: This condition aligns with hypotonia and hyporeflexia but does not typically present with obesity. Key symptoms not reported include progressive muscle weakness. 
+4 Congenital Myopathy: This could explain hypotonia and strabismus but may not account for obesity or fever. Key symptoms not reported include muscle weakness and delayed motor milestones. 
+5 Urea Cycle Disorder: The abnormal amino acid concentration suggests a metabolic issue, but the other symptoms do not align perfectly. Key symptoms not reported include vomiting and lethargy during metabolic crises.",Hereditary metabolic disorders
['Phenylketonuria'],"+1: Phenylketonuria (PKU): Symptoms consistent include hyperphenylalaninemia. Key symptoms not reported include developmental delays and intellectual disability.
+2: Tyrosinemia: Symptoms consistent include hypertyrosinemia. Key symptoms not reported include liver dysfunction and neurological issues.
+3: Congenital Heart Disease: Symptoms consistent include coarctation of the aorta. Key symptoms not reported include other congenital heart defects or syndromic features.
+4: Prader-Willi Syndrome: Symptoms consistent include obesity. Key symptoms not reported include hypogonadism and developmental delays.
+5: Metabolic Syndrome: Symptoms consistent include obesity. Key symptoms not reported include insulin resistance and dyslipidemia.",Hereditary metabolic disorders
['Homocystinuria due to cystathionine beta-synthase deficiency'],"+1 Homocystinuria: This condition is consistent with hyperhomocystinemia and hypermethioninemia, along with developmental abnormalities and early mortality. Key symptoms not reported include skeletal abnormalities and thromboembolic events. 
+2 Methionine adenosyltransferase deficiency: This disorder aligns with hypermethioninemia and could explain the developmental issues and early death. Key symptoms not reported include neurological impairment. 
+3 Cystathionine beta-synthase deficiency: This is a form of homocystinuria that fits the patient's symptoms of hyperhomocystinemia and early mortality. Key symptoms not reported include lens dislocation and vascular complications. 
+4 Maple syrup urine disease (MSUD): While primarily associated with branched-chain amino acids, the presence of aminoaciduria suggests a broader metabolic issue. Key symptoms not reported include characteristic sweet-smelling urine and neurological decline. 
+5 Urea cycle disorders: These can lead to severe metabolic crises and early death, but the specific symptoms of hyperhomocystinemia and hypermethioninemia are less characteristic. Key symptoms not reported include hyperammonemia and altered mental status.",Hereditary metabolic disorders
[],"+1: Pyrimidine Metabolism Disorder: Symptoms consistent include abnormal circulating pyrimidine concentration and uraciluria. Key symptoms not reported may include developmental delays or seizures. 
+2: Adenylosuccinate Lyase Deficiency: Symptoms consistent include ataxia and hypotonia. Key symptoms not reported may include developmental regression or behavioral issues. 
+3: Mitochondrial Disorder: Symptoms consistent include ataxia and hypotonia. Key symptoms not reported may include myopathy or exercise intolerance. 
+4: Cerebral Folate Deficiency: Symptoms consistent include ataxia and hypotonia. Key symptoms not reported may include seizures or developmental delays. 
+5: Urea Cycle Disorder: Symptoms consistent include neurological symptoms. Key symptoms not reported may include hyperammonemia or metabolic crises.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Tyrosinemia type I: This condition is consistent with hypertyrosinemia and can lead to severe complications, including early death. Key symptoms not reported include liver dysfunction and renal issues. 
+2 Phenylketonuria (PKU): Hyperphenylalaninemia aligns with this diagnosis, but the presence of hypertyrosinemia is atypical. Key symptoms not reported include developmental delays and neurological issues. 
+3 Combined metabolic disorder: This could explain the simultaneous elevation of both tyrosine and phenylalanine, but specific conditions would need to be identified. Key symptoms not reported include specific metabolic crisis episodes. 
+4 Urea cycle disorder: While this could lead to elevated amino acids, it does not specifically explain the combination of symptoms. Key symptoms not reported include hyperammonemia and neurological symptoms. 
+5 Maple syrup urine disease (MSUD): This condition is less likely due to the specific amino acid elevations but could be considered if branched-chain amino acids are also elevated. Key symptoms not reported include characteristic urine odor and neurological decline.",Hereditary metabolic disorders
[],"+1 Orotic Aciduria: This condition is characterized by abnormal pyrimidine metabolism, leading to elevated uracil levels and can result in severe neonatal outcomes. 
+2 Pyrimidine Metabolism Disorder: This encompasses a range of conditions that could explain the abnormal circulating pyrimidine concentration and uraciluria, along with respiratory issues. 
+3 Mitochondrial Myopathy: While this could explain respiratory insufficiency and early death, it typically presents with additional symptoms such as muscle weakness or neurological issues. 
+4 Urea Cycle Disorder: This could lead to respiratory distress and metabolic issues, but does not specifically account for the abnormal pyrimidine levels. 
+5 Severe Combined Immunodeficiency (SCID): This could lead to respiratory issues and early death, but does not typically present with abnormal pyrimidine levels.",Hereditary metabolic disorders
['Tyrosinemia type 1'],"+1 Hepatic dysfunction: Symptoms consistent include elevated alkaline phosphatase, hypoalbuminemia, ascites, and anemia. Key symptoms not reported may include jaundice or specific liver pain. 
+2 Tyrosinemia: Symptoms consistent include hypertyrosinemia, aminoaciduria, and possible ascites. Key symptoms not reported may include neurological symptoms or failure to thrive. 
+3 Neonatal hemochromatosis: Symptoms consistent include anemia, ascites, and elevated liver enzymes. Key symptoms not reported may include jaundice or specific liver dysfunction signs. 
+4 Alpha-1 antitrypsin deficiency: Symptoms consistent include elevated alpha-fetoprotein and liver dysfunction signs. Key symptoms not reported may include respiratory issues or liver cirrhosis signs. 
+5 Congenital infections (e.g., TORCH complex): Symptoms consistent include ascites and anemia. Key symptoms not reported may include rash, fever, or other signs of infection.",Hereditary metabolic disorders
['Canavan disease'],"+1 Urea Cycle Disorder: Seizures, motor delay. Key symptoms not reported: Hyperammonemia, lethargy. 
+2 Maple Syrup Urine Disease: Seizures, motor delay. Key symptoms not reported: Distinctive urine odor, feeding difficulties. 
+3 Non-ketotic Hyperglycinemia: Seizures, motor delay. Key symptoms not reported: Hypotonia, apnea. 
+4 Phenylketonuria: Seizures, motor delay. Key symptoms not reported: Intellectual disability, eczema. 
+5 Amino Acid Metabolism Disorder: Seizures, motor delay, abnormal amino acid levels. Key symptoms not reported: Varies by specific disorder.",Hereditary metabolic disorders
['Isovaleric acidemia'],"+1 Urea Cycle Disorder: This condition could explain the abnormal amino acid levels and severe symptoms leading to early death. Key symptoms not reported include lethargy and neurological deficits. 
+2 Organic Acidemia: Conditions like propionic acidemia could lead to gastrointestinal distress and metabolic derangements. Key symptoms not reported include metabolic acidosis and developmental delays. 
+3 Glycine Encephalopathy: Elevated glycine levels could explain recurrent infections and developmental issues. Key symptoms not reported include seizures and hypotonia. 
+4 Carnitine Transport Defect: This could explain the abnormal carnitine levels and metabolic crises. Key symptoms not reported include muscle weakness and cardiomyopathy. 
+5 Cystic Fibrosis: Gastrointestinal symptoms and recurrent infections fit, but metabolic abnormalities do not align. Key symptoms not reported include chronic respiratory issues and pancreatic insufficiency.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Phenylketonuria (PKU): Consistent symptoms include hyperphenylalaninemia and intellectual disability. Key symptoms not reported include severe developmental delays if untreated.
+2 Tyrosinemia: Consistent symptoms include hypertyrosinemia and potential neurological issues. Key symptoms not reported include liver dysfunction and acute metabolic crises.
+3 Maple Syrup Urine Disease (MSUD): Consistent symptoms include elevated urinary carboxylic acids. Key symptoms not reported include specific neurological symptoms and metabolic crises.
+4 Urea Cycle Disorders: Consistent symptoms include elevated urinary carboxylic acids. Key symptoms not reported include hyperammonemia and acute neurological symptoms.
+5 Bardet-Biedl Syndrome: Consistent symptoms include obesity, intellectual disability, and hypertension. Key symptoms not reported include retinal dystrophy and polydactyly.",Hereditary metabolic disorders
['Medium chain acyl-CoA dehydrogenase deficiency'],"+1: Urea Cycle Disorder: Symptoms consistent include hyperalaninemia and potential neonatal death. Key symptoms not reported may include elevated ammonia levels and neurological symptoms. 
+2: Fatty Acid Oxidation Disorder: Symptoms consistent include abnormal circulating carnitine concentration and potential death in infancy. Key symptoms not reported may include hypoglycemia and cardiomyopathy. 
+3: Maple Syrup Urine Disease: Symptoms consistent include hyperalaninemia and severe hearing impairment. Key symptoms not reported may include characteristic urine odor and neurological decline. 
+4: Mitochondrial Disorder: Symptoms consistent include severe hearing impairment and potential death in childhood. Key symptoms not reported may include muscle weakness and exercise intolerance. 
+5: Genetic Syndrome (e.g., Alpers-Huttenlocher syndrome): Symptoms consistent include severe hearing impairment and death in infancy. Key symptoms not reported may include seizures and developmental delays.",Hereditary metabolic disorders
['Ornithine transcarbamylase deficiency'],"+1 Ornithine transcarbamylase deficiency (OTC deficiency): Symptoms consistent include lethargy, drowsiness, orotic aciduria, and abnormal ornithine concentration. Key symptoms not reported may include hyperammonemia and neurological deficits during metabolic crises. 
+2 Carbamoyl phosphate synthetase I deficiency: Symptoms consistent include lethargy, drowsiness, and orotic aciduria. Key symptoms not reported may include severe metabolic crises and hyperammonemia. 
+3 Citrullinemia: Symptoms consistent include lethargy and abnormal ornithine concentration. Key symptoms not reported may include acute neurological symptoms and hyperammonemia. 
+4 Urea cycle disorder (unspecified): Symptoms consistent include lethargy, drowsiness, and orotic aciduria. Key symptoms not reported may include specific metabolic crisis symptoms depending on the exact disorder. 
+5 Mitochondrial disorders: Symptoms consistent include lethargy and sleep abnormalities. Key symptoms not reported may include muscle weakness and exercise intolerance.",Hereditary metabolic disorders
['Glutaryl-CoA dehydrogenase deficiency'],"+1 Glutaric Aciduria Type I: Symptoms consistent with this diagnosis include glutaric aciduria, ataxia, and dystonia. Key symptoms not reported include episodes of metabolic crisis and potential developmental delays. 
+2 Carnitine Palmitoyltransferase I Deficiency: Symptoms consistent with this diagnosis include decreased plasma free carnitine and neurological symptoms like ataxia. Key symptoms not reported include hypoketotic hypoglycemia and muscle weakness during fasting. 
+3 Pelizaeus-Merzbacher Disease: Symptoms consistent with this diagnosis include abnormal myelination and neurological symptoms like ataxia. Key symptoms not reported include spasticity and developmental delays. 
+4 Krabbe Disease: Symptoms consistent with this diagnosis include abnormal myelination and neurological decline leading to death in childhood. Key symptoms not reported include irritability and loss of milestones. 
+5 Alexander Disease: Symptoms consistent with this diagnosis include abnormal cerebral morphology and neurological symptoms like ataxia. Key symptoms not reported include macrocephaly and seizures.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Phenylketonuria (PKU): This condition is characterized by hyperphenylalaninemia and can lead to severe neurological damage and death in untreated infants. 
+2 Tyrosinemia: This condition can present with hyperphenylalaninemia but typically includes additional symptoms such as liver dysfunction, which are not reported here. 
+3 Maple Syrup Urine Disease (MSUD): This disorder can cause elevated phenylalanine levels but usually presents with neurological symptoms and a distinctive urine odor, which are absent in this case. 
+4 Urea Cycle Disorders: These can lead to hyperammonemia and may present with similar symptoms, but they typically involve other metabolic derangements not indicated here. 
+5 Other rare metabolic disorders: Various rare conditions can cause hyperphenylalaninemia, but they are less common and would require specific genetic testing to confirm.",Hereditary metabolic disorders
['Systemic primary carnitine deficiency'],"+1: Fatty Acid Oxidation Disorder: Symptoms consistent include decreased plasma free carnitine, hypoglycemia, cardiomyopathy, and hepatomegaly. Key symptoms not reported may include episodes of hypoketotic hypoglycemia during fasting. 
+2: Organic Acidemia: Symptoms consistent include encephalopathy, vomiting, hypoglycemia, and abnormal amino acid concentrations. Key symptoms not reported may include metabolic acidosis or specific odor in urine.
+3: Urea Cycle Disorder: Symptoms consistent include irritability, coma, and encephalopathy. Key symptoms not reported may include elevated plasma ammonia levels.
+4: Mitochondrial Disorder: Symptoms consistent include generalized hypotonia, cardiomyopathy, and encephalopathy. Key symptoms not reported may include exercise intolerance or myopathy.
+5: Porphyria: Symptoms consistent include abnormal circulating porphyrin concentration. Key symptoms not reported may include photosensitivity or abdominal pain.",Hereditary metabolic disorders
['PMM2-CDG'],"+1 Cerebellar Agenesis: Symptoms consistent include cerebellar atrophy, ataxia, hypotonia, and motor delay. Key symptoms not reported may include specific cognitive impairments or seizures.
+2 Joubert Syndrome: Symptoms consistent include ataxia, hypotonia, and developmental delays. Key symptoms not reported may include eye movement abnormalities or breathing irregularities.
+3 Mitochondrial Disorders: Symptoms consistent include hypotonia, ataxia, and encephalopathy. Key symptoms not reported may include muscle weakness or exercise intolerance.
+4 Congenital Disorders of Glycosylation: Symptoms consistent include encephalopathy and growth delay. Key symptoms not reported may include liver dysfunction or coagulopathy.
+5 Lissencephaly: Symptoms consistent include developmental delays and hypotonia. Key symptoms not reported may include seizures or specific cognitive deficits.",Hereditary metabolic disorders
['Homocystinuria due to cystathionine beta-synthase deficiency'],"+1 Homocystinuria: This condition is characterized by elevated levels of homocysteine in the blood, which aligns with the patient's hyperhomocystinemia. Symptoms include myopia, ectopia lentis, and intellectual disability. Key symptoms not reported include thromboembolic events and skeletal abnormalities.

+2 Marfan syndrome: This genetic disorder can present with myopia and ectopia lentis, along with potential intellectual disability. However, the presence of hyperhomocystinemia and aminoaciduria may not fit as well. Key symptoms not reported include cardiovascular issues and tall stature.

+3 Cystathionine beta-synthase deficiency: This metabolic disorder leads to homocystinuria and presents with similar symptoms, including intellectual disability and ectopia lentis. Key symptoms not reported include developmental delays and seizures.

+4 Maple syrup urine disease: This condition can cause aminoaciduria and developmental delays. However, it typically presents with a distinct odor in urine and does not commonly feature ectopia lentis. Key symptoms not reported include feeding difficulties and lethargy.

+5 Phenylketonuria (PKU): This metabolic disorder leads to aminoaciduria and intellectual disability. However, it does not typically present with ectopia lentis or hyperhomocystinemia. Key symptoms not reported include a musty odor in urine and skin rashes.",Hereditary metabolic disorders
['Ornithine transcarbamylase deficiency'],"+1 Ornithine Transcarbamylase Deficiency: Symptoms consistent include hyperammonemia, orotic aciduria, seizures, ataxia, and lethargy. Key symptoms not reported include specific dietary triggers or family history of metabolic disorders. 
+2 Mitochondrial Encephalomyopathy (MELAS): Symptoms consistent include seizures, ataxia, and drowsiness. Key symptoms not reported include lactic acidosis and stroke-like episodes. 
+3 Urea Cycle Disorder (Argininosuccinate Synthetase Deficiency): Symptoms consistent include hyperammonemia and neurological symptoms. Key symptoms not reported include specific metabolic crises or developmental delays. 
+4 Maple Syrup Urine Disease: Symptoms consistent include neurological symptoms and metabolic acidosis. Key symptoms not reported include characteristic sweet-smelling urine and specific amino acid imbalances. 
+5 Non-ketotic Hyperglycinemia: Symptoms consistent include seizures and lethargy. Key symptoms not reported include specific glycine accumulation and developmental delays.",Hereditary metabolic disorders
['Smith-Lemli-Opitz syndrome'],"+1 Smith-Lemli-Opitz syndrome: This condition is consistent with microcephaly, intellectual disability, syndactyly, and elevated 7-dehydrocholesterol levels. Key symptoms not reported include congenital heart defects and behavioral issues. 
+2 Cornelia de Lange syndrome: This syndrome could explain microcephaly, strabismus, ptosis, and failure to thrive. Key symptoms not reported include limb malformations and facial dysmorphism. 
+3 Zellweger spectrum disorders: These disorders can present with hypotonia, ataxia, and failure to thrive, along with dysmorphic features. Key symptoms not reported include liver dysfunction and vision problems. 
+4 Kallmann syndrome: This condition may explain some neurological symptoms and hypotonia, but it typically includes hypogonadism and anosmia, which are not reported. 
+5 Mucopolysaccharidosis: This group of disorders can present with developmental delays, hypotonia, and dysmorphic features, but typically includes skeletal abnormalities and organomegaly, which are not mentioned.",Hereditary metabolic disorders
['Glycogen storage disease due to glycogen debranching enzyme deficiency'],"+1 Mitochondrial disorder: Generalized hypotonia, increased circulating lactate concentration, neonatal death. Key symptoms not reported: Myopathy, seizures, or developmental delays. 
+2 Glycogen storage disease: Hepatomegaly, hypertriglyceridemia, abnormal amino acid concentrations. Key symptoms not reported: Hypoglycemia, growth retardation. 
+3 Fatty acid oxidation disorder: Generalized hypotonia, hypertriglyceridemia, increased lactate concentration. Key symptoms not reported: Hypoglycemia, episodes of metabolic crisis. 
+4 Urea cycle disorder: Abnormal circulating aspartate and alanine concentrations. Key symptoms not reported: Hyperammonemia, altered mental status. 
+5 Lysosomal storage disorder (e.g., Pompe disease): Generalized hypotonia, elevated creatine kinase, hepatomegaly. Key symptoms not reported: Cardiomyopathy, progressive weakness.",Hereditary metabolic disorders
['Glutaryl-CoA dehydrogenase deficiency'],"+1 Glutaric Aciduria Type I: Symptoms include microcephaly, generalized hypotonia, cerebral cortical atrophy, and abnormal circulating acylcarnitine concentration. Key symptoms not reported include acute metabolic crises or episodes of encephalopathy. 
+2 Mitochondrial Disorder: Symptoms include hypotonia and developmental delays. Key symptoms not reported include exercise intolerance or myopathy. 
+3 Urea Cycle Disorder: Symptoms include neurological symptoms and metabolic crises. Key symptoms not reported include hyperammonemia or acute encephalopathy. 
+4 Peroxisomal Disorder: Symptoms include hypotonia and developmental delays. Key symptoms not reported include seizures or specific dysmorphic features. 
+5 Congenital Disorder of Glycosylation: Symptoms include hypotonia and developmental delays. Key symptoms not reported include specific dysmorphic features or organomegaly.",Hereditary metabolic disorders
['Propionic acidemia'],"+1 Urea Cycle Disorder: Symptoms include hyperammonemia and abnormal glutamine levels. Key symptoms not reported include lethargy and neurological deficits. 
+2 Non-ketotic Hyperglycinemia: Symptoms include hyperglycinemia and hyperglycinuria. Key symptoms not reported include seizures and developmental delays. 
+3 Fatty Acid Oxidation Disorder: Symptoms include elevated urinary carboxylic acid and abnormal carnitine levels. Key symptoms not reported include hypoglycemia and muscle weakness. 
+4 Organic Acidemia: Symptoms include elevated urinary carboxylic acid and metabolic acidosis. Key symptoms not reported include failure to thrive and metabolic crises. 
+5 Mitochondrial Disorder: Symptoms may include a combination of metabolic derangements and ichthyosis. Key symptoms not reported include exercise intolerance and myopathy.",Hereditary metabolic disorders
['Succinic semialdehyde dehydrogenase deficiency'],"+1 Genetic Syndrome: 
Intellectual disability, motor delay, abnormal facial shape, abnormal calvaria morphology. 
Key symptoms not reported: Specific genetic markers or family history of similar conditions.

+2 Organic Acidemia: 
Abnormal circulating monocarboxylic acid concentration, elevated urinary carboxylic acid, intellectual disability, motor delay. 
Key symptoms not reported: Episodes of metabolic crisis or acidosis.

+3 Mitochondrial Disorder: 
Intellectual disability, motor delay, abnormal facial shape, death in childhood. 
Key symptoms not reported: Muscle weakness, exercise intolerance, or seizures.

+4 Craniosynostosis Syndrome: 
Abnormal facial shape, abnormal calvaria morphology, intellectual disability. 
Key symptoms not reported: Specific craniofacial features or associated syndromic traits.

+5 Peroxisomal Disorder: 
Intellectual disability, motor delay, abnormal facial shape, elevated urinary carboxylic acid. 
Key symptoms not reported: Hepatic dysfunction or specific biochemical markers.",Hereditary metabolic disorders
['Classic galactosemia'],"+1 Galactosemia: Symptoms consistent include hypergalactosemia, hepatic failure, and developmental delays. Key symptoms not reported may include cataracts and renal issues. 
+2 Urea Cycle Disorder: Symptoms consistent include intellectual disability and motor delay. Key symptoms not reported may include episodes of hyperammonemia and vomiting. 
+3 Tyrosinemia: Symptoms consistent include hepatic failure and developmental delays. Key symptoms not reported may include renal tubular dysfunction and a specific odor in urine. 
+4 Maple Syrup Urine Disease: Symptoms consistent include intellectual disability and motor delay. Key symptoms not reported may include a characteristic sweet odor in urine and episodes of metabolic crisis. 
+5 Fructose Intolerance: Symptoms consistent include hepatic failure and diarrhea. Key symptoms not reported may include hypoglycemia and aversion to fructose-containing foods.",Hereditary metabolic disorders
['Neonatal intrahepatic cholestasis due to citrin deficiency'],"+1 Citrullinemia: Symptoms consistent include hyperammonemia, elevated plasma citrulline, and aminoaciduria. Key symptoms not reported may include neurological symptoms due to ammonia toxicity. 
+2 Argininosuccinic aciduria: Symptoms consistent include hyperammonemia and aminoaciduria. Key symptoms not reported may include failure to thrive and developmental delays. 
+3 Prolinemia: Symptoms consistent include abnormal circulating proline concentration and aminoaciduria. Key symptoms not reported may include neurological symptoms and skin lesions. 
+4 Ornithine transcarbamylase deficiency: Symptoms consistent include hyperammonemia and neonatal death. Key symptoms not reported may include lethargy and seizures. 
+5 Hyperornithinemia: Symptoms consistent include elevated plasma citrulline and aminoaciduria. Key symptoms not reported may include developmental delays and neurological issues.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Metabolic Disorder (e.g., Tyrosinemia Type I): Symptoms consistent include hypertyrosinemia, recurrent infections, and potential liver dysfunction. Key symptoms not reported may include hepatomegaly or renal issues. 
+2 Phenylketonuria (PKU): Symptoms consistent include hyperphenylalaninemia and potential developmental delays. Key symptoms not reported may include intellectual disability or behavioral issues. 
+3 Urea Cycle Disorder: Symptoms consistent include recurrent infections and metabolic crises. Key symptoms not reported may include hyperammonemia or neurological symptoms. 
+4 Porphyria: Symptoms consistent include abnormal circulating porphyrin concentration and potential neurological symptoms. Key symptoms not reported may include photosensitivity or abdominal pain. 
+5 Iron Deficiency Anemia: Symptoms consistent include decreased circulating ferritin concentration and potential fatigue or weakness. Key symptoms not reported may include pallor or shortness of breath.",Hereditary metabolic disorders
['Maple syrup urine disease'],"+1 Maple Syrup Urine Disease (MSUD): Symptoms consistent include lethargy, generalized hypotonia, tremor, and abnormal circulating leucine concentration. Key symptoms not reported include a characteristic sweet odor of urine. 
+2 Urea Cycle Disorder: Symptoms consistent include lethargy, drowsiness, and hypotonia. Key symptoms not reported include hyperammonemia and potential seizures. 
+3 Organic Acidemia: Symptoms consistent include lethargy, hypotonia, and elevated urinary carboxylic acid. Key symptoms not reported include metabolic acidosis and specific organic acid profiles in urine. 
+4 Mitochondrial Disorder: Symptoms consistent include lethargy, hypotonia, and sleep abnormalities. Key symptoms not reported include exercise intolerance and potential myopathy. 
+5 Phenylketonuria (PKU): Symptoms consistent include lethargy and hypotonia. Key symptoms not reported include intellectual disability and a musty body odor.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Tyrosinemia: Symptoms consistent include hypertyrosinemia and generalized hypotonia. Key symptoms not reported include liver dysfunction and renal issues. 
+2 Phenylketonuria (PKU): Symptoms consistent include hyperphenylalaninemia and hypotonia. Key symptoms not reported include developmental delays and seizures. 
+3 Iron Deficiency Anemia: Symptoms consistent include anemia and decreased circulating iron concentration. Key symptoms not reported include fatigue and pallor. 
+4 Metabolic Disorder (unspecified): Symptoms consistent include generalized hypotonia, anemia, and abnormal vitamin D metabolism. Key symptoms not reported include specific metabolic derangements. 
+5 Genetic Syndrome (e.g., Maple Syrup Urine Disease): Symptoms consistent include hypotonia and potential metabolic derangements. Key symptoms not reported include characteristic urine odor and neurological symptoms.",Hereditary metabolic disorders
['Smith-Lemli-Opitz syndrome'],"+1 Smith-Lemli-Opitz syndrome: This condition is consistent with hypertelorism, anteverted nares, syndactyly, intellectual disability, seizures, and hypocholesterolemia. Key symptoms not reported include congenital heart defects and genital anomalies. 
+2 Cornelia de Lange syndrome: This syndrome can present with facial dysmorphisms, intellectual disability, and behavioral issues. However, it may not fully explain the metabolic abnormalities or the specific combination of symptoms. Key symptoms not reported include growth delays and limb malformations. 
+3 Apert syndrome: This condition is characterized by craniosynostosis, syndactyly, and intellectual disability. While it explains some features, it does not account for the metabolic issues or the specific hearing impairment. Key symptoms not reported include craniofacial abnormalities and hearing loss. 
+4 22q11.2 deletion syndrome: This syndrome can present with developmental delays, intellectual disability, and various physical anomalies. However, it does not fully explain the specific combination of symptoms like hypocholesterolemia. Key symptoms not reported include cardiac defects and immune deficiencies. 
+5 Fragile X syndrome: This genetic condition is associated with intellectual disability and behavioral issues, but it does not explain the physical anomalies like hypertelorism and syndactyly. Key symptoms not reported include macroorchidism and specific behavioral phenotypes.",Hereditary metabolic disorders
['Vitamin B12-unresponsive methylmalonic acidemia'],"+1 Methylmalonic acidemia: Symptoms consistent include metabolic acidosis, hyperammonemia, elevated methylmalonic aciduria, and failure to thrive. Key symptoms not reported may include specific neurological deficits or seizures. 
+2 Urea cycle disorder: Symptoms consistent include hyperammonemia, failure to thrive, and developmental delays. Key symptoms not reported may include episodic vomiting or altered mental status during metabolic crises. 
+3 Organic acidemia: Symptoms consistent include metabolic acidosis, increased circulating lactate, and feeding difficulties. Key symptoms not reported may include specific metabolic crises or acute decompensation episodes. 
+4 Glycine encephalopathy: Symptoms consistent include hyperglycinemia, hypotonia, and developmental delays. Key symptoms not reported may include seizures or specific neurological findings. 
+5 Peroxisomal disorder: Symptoms consistent include microcephaly, hypotonia, and failure to thrive. Key symptoms not reported may include specific dysmorphic features or additional systemic involvement.",Hereditary metabolic disorders
[],"+1 Pyrimidine Metabolism Disorder: This condition aligns with the abnormal circulating pyrimidine concentration and uraciluria, along with neurological symptoms like ataxia and hypotonia. Key symptoms not reported may include developmental delays or seizures. 
+2 Mitochondrial Disorder: This could explain the lethargy and neurological symptoms, but does not typically present with uraciluria. Key symptoms not reported may include exercise intolerance or myopathy. 
+3 Cerebral Palsy: This could account for ataxia and hypotonia, but does not explain the biochemical abnormalities. Key symptoms not reported may include spasticity or developmental delays. 
+4 Urea Cycle Disorder: While it could explain some metabolic issues, it does not fit well with the specific symptoms and uraciluria. Key symptoms not reported may include hyperammonemia or vomiting. 
+5 Lysosomal Storage Disorder: This could explain hypotonia and neurological symptoms, but the specific biochemical findings would not typically match. Key symptoms not reported may include organomegaly or skeletal abnormalities.",Hereditary metabolic disorders
['Isovaleric acidemia'],"+1 Urea Cycle Disorders: Hyperammonemia, death in infancy, abnormality of prenatal development. Key symptoms not reported: Neurological symptoms (e.g., lethargy, seizures).
+2 Non-ketotic Hyperglycinemia: Abnormal circulating glycine concentration, death in infancy. Key symptoms not reported: Neurological impairment, hypotonia.
+3 Carnitine Transport Defect: Abnormal circulating carnitine concentration, death in infancy. Key symptoms not reported: Muscle weakness, hypoglycemia.
+4 Organic Acidemias: Abnormality of prenatal development, death in infancy. Key symptoms not reported: Metabolic acidosis, failure to thrive.
+5 Mitochondrial Disorders: Abnormality of prenatal development, death in childhood. Key symptoms not reported: Developmental delays, metabolic crises.",Hereditary metabolic disorders
['Biotinidase deficiency'],"+1 Organic acidemia: This condition is consistent with elevated urinary carboxylic acid and can lead to seizures and hypotonia. Key symptoms not reported may include metabolic crises or acidosis.
+2 Mitochondrial disorder: This could explain the neurological symptoms and hypotonia. Key symptoms not reported may include exercise intolerance or developmental delays.
+3 Urea cycle disorder: This could lead to seizures and hypotonia, but typically presents with hyperammonemia. Key symptoms not reported may include vomiting or lethargy.
+4 Genetic syndromes (e.g., Zellweger syndrome): This could explain the combination of symptoms and early mortality. Key symptoms not reported may include dysmorphic features or liver dysfunction.
+5 Neuromuscular disorder: This could explain hypotonia and seizures, but the metabolic findings are less typical. Key symptoms not reported may include muscle weakness or atrophy.",Hereditary metabolic disorders
['Medium chain acyl-CoA dehydrogenase deficiency'],"+1 Carnitine Palmitoyltransferase I or II Deficiency: This condition is consistent with decreased plasma free carnitine and developmental delays. Key symptoms not reported include muscle weakness and hypoglycemia during fasting.
+2 Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCADD): Fits with decreased 3-hydroxyacyl-CoA dehydrogenase levels and the potential for neonatal death. Key symptoms not reported include hypoketotic hypoglycemia and vomiting.
+3 Mitochondrial Myopathy: Could explain developmental delays and metabolic issues, but less specific to the enzyme levels. Key symptoms not reported include exercise intolerance and muscle pain.
+4 Organic Acidemia (e.g., Propionic Acidemia): Could lead to metabolic crises and developmental delays. Key symptoms not reported include metabolic acidosis and failure to thrive.
+5 Urea Cycle Disorders: May explain developmental delays and metabolic crises, but enzyme levels do not directly correlate. Key symptoms not reported include hyperammonemia and neurological symptoms during metabolic decompensation.",Hereditary metabolic disorders
['Maple syrup urine disease'],"+1 Maple Syrup Urine Disease (MSUD): Symptoms consistent include hypervalinemia, hyperleucinemia, hyperisoleucinemia, seizures, and hypotonia. Key symptoms not reported include metabolic crises or specific neurological deficits during acute episodes. 
+2 Urea Cycle Disorder: Symptoms consistent include metabolic acidosis and neurological symptoms. Key symptoms not reported include hyperammonemia and specific amino acid abnormalities typical of this disorder. 
+3 Non-ketotic Hyperglycinemia: Symptoms consistent include seizures and hypotonia. Key symptoms not reported include elevated glycine levels in the blood and specific neurological manifestations. 
+4 Glycine Encephalopathy: Symptoms consistent include seizures and hypotonia. Key symptoms not reported include specific metabolic derangements and elevated glycine levels. 
+5 Spinal Muscular Atrophy (SMA): Symptoms consistent include hypotonia and motor delay. Key symptoms not reported include progressive muscle weakness and specific genetic markers.",Hereditary metabolic disorders
['Propionic acidemia'],"+1: Urea Cycle Disorder: Symptoms consistent include hyperammonemia, psychosis, and intellectual disability. Key symptoms not reported include vomiting and lethargy during metabolic crises. 
+2: Non-ketotic Hyperglycinemia: Symptoms consistent include hyperglycinemia, psychosis, and severe intellectual disability. Key symptoms not reported include seizures and hypotonia. 
+3: Maple Syrup Urine Disease: Symptoms consistent include elevated urinary carboxylic acid and body odor. Key symptoms not reported include feeding difficulties and neurological decline. 
+4: Phenylketonuria (PKU): Symptoms consistent include intellectual disability and body odor. Key symptoms not reported include eczema and seizures. 
+5: Mitochondrial Disorder: Symptoms consistent include cerebral atrophy, osteoporosis, and kyphoscoliosis. Key symptoms not reported include exercise intolerance and lactic acidosis.",Hereditary metabolic disorders
['L-2-hydroxyglutaric aciduria'],"+1 L-2-hydroxyglutaric aciduria: Symptoms include intellectual disability, seizures, ataxia, and tremor. Key symptoms not reported include specific metabolic crises or episodes. 
+2 Glutaric aciduria type I: Symptoms include intellectual disability, seizures, and movement disorders. Key symptoms not reported include specific metabolic crises or characteristic imaging findings. 
+3 Mitochondrial disorders: Symptoms include seizures, ataxia, and developmental delays. Key symptoms not reported include specific muscle weakness or exercise intolerance. 
+4 Batten disease: Symptoms include intellectual disability, seizures, and movement disorders. Key symptoms not reported include vision loss or specific eye abnormalities. 
+5 Aicardi syndrome: Symptoms include seizures and developmental delays. Key symptoms not reported include eye abnormalities or specific neurological deficits.",Hereditary metabolic disorders
['Canavan disease'],"+1: Urea Cycle Disorder: Symptoms consistent include abnormal amino acid concentration and potential motor delay due to metabolic crisis. Key symptoms not reported may include hyperammonemia and lethargy. 
+2: Maple Syrup Urine Disease: Symptoms consistent include abnormal amino acid concentration and motor delay. Key symptoms not reported may include characteristic sweet-smelling urine and feeding difficulties. 
+3: Phenylketonuria (PKU): Symptoms consistent include abnormal amino acid concentration and potential developmental delays. Key symptoms not reported may include intellectual disability and seizures if untreated. 
+4: Spinal Muscular Atrophy (SMA): Symptoms consistent include motor delay and death in infancy. Key symptoms not reported may include muscle weakness and atrophy. 
+5: Krabbe Disease: Symptoms consistent include motor delay and early death. Key symptoms not reported may include irritability, feeding difficulties, and loss of developmental milestones.",Hereditary metabolic disorders
['Citrullinemia type I'],"+1 Citrullinemia: Hyperammonemia, Elevated plasma citrulline, Increased total bilirubin. Key symptoms not reported: Neurological symptoms such as lethargy or seizures.
+2 Ornithine Transcarbamylase Deficiency: Hyperammonemia, Increased total bilirubin. Key symptoms not reported: Respiratory distress, metabolic acidosis.
+3 Argininosuccinic Aciduria: Elevated plasma citrulline, Hyperammonemia. Key symptoms not reported: Failure to thrive, developmental delays.
+4 Hepatic Encephalopathy: Hyperammonemia, Increased total bilirubin. Key symptoms not reported: Altered mental status, confusion.
+5 Neonatal Hepatitis: Increased total bilirubin, Hyperammonemia. Key symptoms not reported: Jaundice, hepatomegaly.",Hereditary metabolic disorders
['3-hydroxy-3-methylglutaric aciduria'],"+1 Urea Cycle Disorder: This diagnosis is supported by hyperammonemia, metabolic acidosis, lethargy, and hepatomegaly. Key symptoms not reported include seizures or neurological deficits.
+2 Organic Acidemia (3-Methylglutaric Aciduria): Consistent with the presence of 3-methylglutaric aciduria and metabolic acidosis. Key symptoms not reported include developmental delays or specific neurological symptoms.
+3 Fatty Acid Oxidation Disorder: Hypoglycemia, vomiting, and lethargy align with this diagnosis. Key symptoms not reported include exercise intolerance or cardiomyopathy.
+4 Mitochondrial Disorder: Lethargy and metabolic acidosis are consistent, but the specific urinary findings may not fit. Key symptoms not reported include myopathy or specific neurological deficits.
+5 Glycogen Storage Disease: Hepatomegaly and hypoglycemia are consistent with this diagnosis. Key symptoms not reported include muscle weakness or growth retardation.",Hereditary metabolic disorders
['Cystinuria'],"+1 Metabolic disorder: This could explain the seizures and splenomegaly. Key symptoms not reported may include developmental delays or feeding difficulties. 
+2 Congenital infection: Conditions like TORCH could lead to splenomegaly and neurological symptoms. Key symptoms not reported may include rash or other systemic signs. 
+3 Hematologic disorder: Conditions such as hemolytic anemia could cause splenomegaly and neurological symptoms. Key symptoms not reported may include jaundice or fatigue. 
+4 Neurodegenerative disorder: Lysosomal storage diseases could present with seizures and splenomegaly. Key symptoms not reported may include progressive neurological decline or developmental regression. 
+5 Congenital malformation syndrome: Certain syndromes could lead to the combination of these symptoms. Key symptoms not reported may include distinct physical features or other organ involvement.",Hereditary metabolic disorders
['Vitamin B12-unresponsive methylmalonic acidemia'],"+1 Urea Cycle Disorder: Symptoms consistent include hyperammonemia, increased blood urea nitrogen, and intellectual disability. Key symptoms not reported may include seizures or lethargy during hyperammonemic episodes. 
+2 Maple Syrup Urine Disease: Symptoms consistent include motor delay, hypotonia, and hypervalinemia. Key symptoms not reported may include a characteristic sweet-smelling urine and feeding difficulties due to metabolic crises. 
+3 Methylmalonic Acidemia: Symptoms consistent include methylmalonic aciduria, vomiting, and hypotonia. Key symptoms not reported may include metabolic acidosis and failure to thrive. 
+4 Propionic Acidemia: Symptoms consistent include vomiting, hypotonia, and increased blood urea nitrogen. Key symptoms not reported may include metabolic acidosis and cardiomyopathy. 
+5 Isovaleric Acidemia: Symptoms consistent include hypotonia and feeding difficulties. Key symptoms not reported may include a distinctive odor of sweaty feet and metabolic crises leading to acute illness.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Tyrosinemia Type I: Symptoms include hypertyrosinemia and severe outcomes in infancy/childhood. Key symptoms not reported include liver dysfunction and renal issues. 
+2 Phenylketonuria (PKU): Symptoms include hyperphenylalaninemia. Key symptoms not reported include developmental delays and neurological issues if untreated. 
+3 Maple Syrup Urine Disease (MSUD): Symptoms include elevated branched-chain amino acids. Key symptoms not reported include characteristic sweet-smelling urine and neurological decline. 
+4 Organic Acidemia: Symptoms include elevated urinary carboxylic acid. Key symptoms not reported include metabolic acidosis and specific organic acid profiles. 
+5 Combined Immunodeficiency: Symptoms include recurrent viral infections. Key symptoms not reported include failure to thrive and opportunistic infections.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Phenylketonuria (PKU): This condition is characterized by hyperphenylalaninemia and can lead to intellectual disability if untreated. The patient exhibits hyperphenylalaninemia and intellectual disability, which are consistent with PKU. Key symptoms not reported include seizures and behavioral issues.

+2 Tyrosinemia: This metabolic disorder is associated with hypertyrosinemia and can lead to neurological issues and developmental delays. The patient has hypertyrosinemia and intellectual disability, aligning with this diagnosis. Key symptoms not reported include liver dysfunction and renal issues.

+3 Bardet-Biedl Syndrome: This genetic disorder can present with obesity, intellectual disability, and strabismus. The patient shows obesity and strabismus, which are consistent with this syndrome. Key symptoms not reported include polydactyly and retinal degeneration.

+4 Prader-Willi Syndrome: This genetic condition is characterized by obesity, intellectual disability, and developmental delays. The patient has obesity and intellectual disability, which fit this diagnosis. Key symptoms not reported include hypotonia and hyperphagia.

+5 Smith-Lemli-Opitz Syndrome: This genetic disorder can present with intellectual disability, strabismus, and obesity. The patient exhibits strabismus and intellectual disability, which are consistent with this syndrome. Key symptoms not reported include congenital malformations and behavioral issues.",Hereditary metabolic disorders
['Ornithine transcarbamylase deficiency'],"+1 Ornithine Transcarbamylase Deficiency: This condition is consistent with hyperammonemia, orotic aciduria, and could explain the abnormal bleeding due to liver dysfunction. Key symptoms not reported include neurological symptoms like lethargy or seizures. 
+2 Citrullinemia: This disorder can also lead to hyperammonemia and vomiting, and may cause bleeding issues due to liver involvement. Key symptoms not reported include developmental delays or neurological symptoms. 
+3 Argininosuccinic Aciduria: This condition presents with hyperammonemia and can lead to similar symptoms, including vomiting and potential bleeding. Key symptoms not reported include developmental delays and neurological symptoms. 
+4 Vitamin K Deficiency: This could explain the abnormal bleeding but does not account for hyperammonemia or orotic aciduria. Key symptoms not reported include easy bruising or bleeding gums. 
+5 Acute Liver Failure: This could explain the combination of symptoms, particularly the abnormal bleeding and hyperammonemia. Key symptoms not reported include jaundice or ascites.",Hereditary metabolic disorders
['L-2-hydroxyglutaric aciduria'],"+1 L-2-hydroxyglutaric acidemia: Symptoms consistent include intellectual disability, generalized hypotonia, hyperreflexia, hyperammonemia, and abnormal cerebral morphology. Key symptoms not reported may include seizures or developmental regression. 
+2 Urea cycle disorder: Symptoms consistent include hyperammonemia and intellectual disability. Key symptoms not reported may include vomiting, lethargy, or irritability during hyperammonemic episodes. 
+3 Organic acidemia: Symptoms consistent include hyperammonemia and neurological impairment. Key symptoms not reported may include metabolic acidosis or specific metabolic derangements. 
+4 Peroxisomal disorders: Symptoms consistent include hypotonia and abnormal myelination. Key symptoms not reported may include seizures or vision/hearing impairment. 
+5 Mitochondrial disorders: Symptoms consistent include hypotonia and developmental delays. Key symptoms not reported may include exercise intolerance or lactic acidosis.",Hereditary metabolic disorders
['PMM2-CDG'],"+1 Genetic Syndrome: Ataxia-telangiectasia. Symptoms consistent: Ataxia, intellectual disability, cerebellar atrophy. Key symptoms not reported: Telangiectasia, immunodeficiency.

+2 Metabolic Disorder: Mitochondrial myopathy. Symptoms consistent: Ataxia, intellectual disability, stroke-like episodes. Key symptoms not reported: Muscle weakness, exercise intolerance.

+3 Cerebellar Degeneration Syndrome: Spinocerebellar ataxia. Symptoms consistent: Ataxia, cerebellar atrophy. Key symptoms not reported: Progressive symptoms over time, family history.

+4 Vascular Malformation: Arteriovenous malformation (AVM). Symptoms consistent: Thromboembolism, stroke-like episodes. Key symptoms not reported: Headaches, seizures.

+5 Neurodegenerative Disorder: Infantile neuroaxonal dystrophy. Symptoms consistent: Intellectual disability, ataxia, death in infancy. Key symptoms not reported: Vision problems, spasticity.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Phenylketonuria (PKU): Symptoms consistent with hyperphenylalaninemia. Key symptoms not reported include neurological impairment or developmental delays.
+2 Tyrosinemia: Symptoms consistent with hypertyrosinemia and potential liver dysfunction. Key symptoms not reported include jaundice or failure to thrive.
+3 Maple Syrup Urine Disease (MSUD): Symptoms consistent with severe metabolic crises in infancy. Key symptoms not reported include characteristic sweet-smelling urine or neurological symptoms.
+4 Urea Cycle Disorders: Symptoms consistent with metabolic disturbances. Key symptoms not reported include hyperammonemia or altered mental status.
+5 Organic Acidemias: Symptoms consistent with severe metabolic disturbances in infancy. Key symptoms not reported include acidosis or specific metabolic crises.",Hereditary metabolic disorders
['Propionic acidemia'],"+1 Urea Cycle Disorder: Symptoms consistent include hyperammonemia, lethargy, seizures, and intellectual disability. Key symptoms not reported may include specific behavioral changes or episodes of vomiting related to hyperammonemia.

+2 Glycine Encephalopathy: Symptoms consistent include hyperglycinemia, seizures, lethargy, and motor delay. Key symptoms not reported may include specific neurological deficits or abnormal movements.

+3 Mitochondrial Disorder: Symptoms consistent include increased circulating lactate concentration, lethargy, motor delay, and seizures. Key symptoms not reported may include exercise intolerance or specific organ involvement.

+4 Organic Acidemia (e.g., Propionic Acidemia): Symptoms consistent include vomiting, lethargy, seizures, and metabolic derangements (elevated lactate). Key symptoms not reported may include metabolic crises triggered by illness or fasting.

+5 Severe Combined Immunodeficiency (SCID): Symptoms consistent include recurrent infections, lethargy, and failure to thrive. Key symptoms not reported may include specific types of infections or failure to respond to vaccinations.",Hereditary metabolic disorders
['Wilson disease'],"+1 Wilson's disease: Polydipsia, elevated hepatic transaminases, decreased ceruloplasmin concentration. Key symptoms not reported: Neurological symptoms, Kayser-Fleischer rings. 
+2 Menkes disease: Decreased ceruloplasmin concentration, decreased copper concentration. Key symptoms not reported: Neurological deterioration, kinky hair. 
+3 Acute liver failure: Elevated hepatic transaminases, polydipsia. Key symptoms not reported: Jaundice, confusion, abdominal pain. 
+4 Copper deficiency: Decreased copper concentration, decreased ceruloplasmin concentration. Key symptoms not reported: Anemia, neutropenia, bone abnormalities. 
+5 Hemochromatosis: Elevated hepatic transaminases. Key symptoms not reported: Joint pain, diabetes, skin pigmentation changes.",Hereditary metabolic disorders
['Ornithine transcarbamylase deficiency'],"+1 Urea Cycle Disorder: This condition can explain hyperglutaminemia and orotic aciduria, along with neurological symptoms like seizures and lethargy. Key symptoms not reported may include irritability and poor feeding.
+2 Amino Acid Metabolism Disorder: Conditions such as Glutamine Synthetase Deficiency could lead to similar metabolic findings and neurological symptoms. Key symptoms not reported may include developmental delays.
+3 Mitochondrial Disorder: These disorders can present with seizures and hypotonia, but the specific metabolic findings may not align perfectly. Key symptoms not reported may include exercise intolerance or myopathy.
+4 Organic Acidemia: While conditions like Propionic Acidemia could present with similar symptoms, the specific metabolic markers are not typical. Key symptoms not reported may include metabolic acidosis or failure to thrive.
+5 Neurodegenerative Disorder: Certain genetic conditions could lead to the reported symptoms, but the metabolic abnormalities are less common. Key symptoms not reported may include progressive loss of skills or abnormal movements.",Hereditary metabolic disorders
['Classic galactosemia'],"+1 Genetic Syndrome: 
Microcephaly, delayed speech and language development, intellectual disability, motor delay, and generalized hypotonia are consistent with various genetic syndromes such as Down syndrome or Williams syndrome. Key symptoms not reported may include distinct facial features or congenital heart defects.

+2 Metabolic Disorder (Galactosemia): 
The presence of hypergalactosemia and feeding difficulties aligns with galactosemia, a metabolic disorder affecting galactose metabolism. Symptoms not reported may include liver dysfunction or cataracts.

+3 Congenital Hypothyroidism: 
The combination of obesity, hypotonia, and developmental delays could suggest congenital hypothyroidism. Symptoms not reported may include dry skin, constipation, or umbilical hernia.

+4 Mitochondrial Disorder: 
The combination of neurological symptoms, hypotonia, and metabolic abnormalities could indicate a mitochondrial disorder. Symptoms not reported may include exercise intolerance or seizures.

+5 Lysosomal Storage Disorder (e.g., Pompe disease): 
The combination of hypotonia, motor delay, and elevated alkaline phosphatase could suggest a lysosomal storage disorder. Symptoms not reported may include cardiomyopathy or progressive weakness.",Hereditary metabolic disorders
['Biotinidase deficiency'],"+1 Prader-Willi Syndrome: This condition is consistent with obesity and abnormal foot morphology. Hyperammonemia is not typical, but metabolic issues can occur. Key symptoms not reported include hypotonia and developmental delays. 
+2 Urea Cycle Disorder: Hyperammonemia is a hallmark of this condition. However, obesity and abnormal foot morphology are not typical features. Key symptoms not reported include neurological deficits and vomiting. 
+3 Glycogen Storage Disease: This could explain obesity and metabolic issues, but hyperammonemia is less common. Key symptoms not reported include muscle weakness and hypoglycemia. 
+4 Congenital Disorders of Glycosylation: This could lead to obesity and abnormal morphology, but hyperammonemia is not typical. Key symptoms not reported include developmental delays and organ dysfunction. 
+5 Metabolic Syndrome: While obesity is a key feature, the other symptoms do not align well, and hyperammonemia is not typically associated. Key symptoms not reported include insulin resistance and hypertension.",Hereditary metabolic disorders
['Canavan disease'],"+1: Urea Cycle Disorder: Symptoms consistent include abnormal circulating aspartate family amino acid concentration and feeding difficulties. Key symptoms not reported include severe neurological symptoms or hyperammonemia.
+2: Phenylketonuria (PKU): Symptoms consistent include feeding difficulties and potential developmental delays. Key symptoms not reported include intellectual disability or seizures.
+3: Maple Syrup Urine Disease: Symptoms consistent include feeding difficulties and potential neurological symptoms. Key symptoms not reported include characteristic urine odor and severe metabolic crises.
+4: Krabbe Disease: Symptoms consistent include abnormal myelination and feeding difficulties. Key symptoms not reported include severe neurological decline and loss of motor skills.
+5: Aspartylglycosaminuria: Symptoms consistent include abnormal circulating aspartate family amino acid concentration. Key symptoms not reported include developmental delays and specific cognitive impairments.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Phenylketonuria (PKU): Symptoms consistent include hyperphenylalaninemia. Key symptoms not reported include developmental delays and neurological issues if untreated. 
+2 Congenital Heart Defects: Symptoms consistent include death in infancy and abnormality of prenatal development. Key symptoms not reported include specific cardiac anomalies or murmurs. 
+3 Metabolic Disorders: Symptoms consistent include hyperphenylalaninemia and death in infancy. Key symptoms not reported include specific metabolic derangements or other metabolic markers. 
+4 Genetic Syndromes: Symptoms consistent include abnormality of prenatal development and death in infancy. Key symptoms not reported include specific phenotypic features or family history of genetic disorders. 
+5 Congenital Infections: Symptoms consistent include abnormality of prenatal development and neonatal death. Key symptoms not reported include signs of infection or specific congenital infection markers.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Phenylketonuria (PKU): Symptoms consistent include hyperphenylalaninemia and delayed speech and language development. Key symptoms not reported include seizures or behavioral issues. 
+2 Tyrosinemia: Symptoms consistent include hypertyrosinemia and developmental delays. Key symptoms not reported include liver dysfunction or renal issues. 
+3 Maple Syrup Urine Disease (MSUD): Symptoms consistent include developmental delays and metabolic abnormalities. Key symptoms not reported include characteristic sweet-smelling urine and feeding difficulties. 
+4 Mitochondrial Disorder: Symptoms consistent include developmental delays and early mortality. Key symptoms not reported include muscle weakness or exercise intolerance. 
+5 Urea Cycle Disorder: Symptoms consistent include developmental delays and metabolic issues. Key symptoms not reported include episodes of hyperammonemia or lethargy.",Hereditary metabolic disorders
[],"+1 Congenital Heart Disease Syndrome: Symptoms include ventricular septal defect, cardiomyopathy, and pulmonic stenosis. Key symptoms not reported may include facial dysmorphism or other congenital anomalies.
+2 Noonan Syndrome: Symptoms include cardiac defects, hypotonia, and nephritis. Key symptoms not reported may include short stature or developmental delays.
+3 Congenital Nephrotic Syndrome: Symptoms include nephritis and hypotonia. Key symptoms not reported may include significant proteinuria or edema.
+4 Turner Syndrome: Symptoms include cardiac defects and hypotonia. Key symptoms not reported may include short stature or ovarian dysgenesis.
+5 Trisomy 18: Symptoms include multiple organ system involvement and hypotonia. Key symptoms not reported may include growth retardation or characteristic facial features.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Tyrosinemia: This condition is characterized by hypertyrosinemia and can lead to neurological symptoms, irritability, and spasticity. Key symptoms not reported include liver dysfunction and renal issues.
+2 Phenylketonuria (PKU): Associated with hyperphenylalaninemia, leading to neurological issues. Key symptoms not reported include developmental delays and seizures.
+3 Severe Combined Immunodeficiency (SCID): Characterized by recurrent infections due to immunodeficiency. Key symptoms not reported include failure to thrive and absence of lymphoid tissue.
+4 Urea Cycle Disorder: Can lead to neurological symptoms due to hyperammonemia. Key symptoms not reported include vomiting, lethargy, and altered mental status.
+5 Spinal Muscular Atrophy (SMA): Explains spasticity and hyperreflexia. Key symptoms not reported include muscle weakness and atrophy.",Hereditary metabolic disorders
['Medium chain acyl-CoA dehydrogenase deficiency'],"+1 Carnitine Palmitoyltransferase I Deficiency: This condition is consistent with the abnormal circulating carnitine concentration and the severe outcomes in infancy. Key symptoms not reported include hypoglycemia and lethargy.

+2 Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCADD): The abnormal carnitine levels and the risk of sudden death in infancy align with this diagnosis. Key symptoms not reported include episodes of hypoglycemia and vomiting.

+3 Congenital Adrenal Hyperplasia (CAH): While there are metabolic disturbances, the specific combination of symptoms may not fully align. Key symptoms not reported include ambiguous genitalia or adrenal crisis.

+4 Mitochondrial Disorders: These can lead to metabolic crises and developmental issues, but the specific symptoms here suggest a more focused metabolic disorder. Key symptoms not reported include muscle weakness or neurological deficits.

+5 Genetic Syndromes (e.g., Zellweger Spectrum Disorders): These can present with multiple congenital anomalies, but the specific symptoms of neonatal death and abnormal carnitine levels may not fit all syndromes. Key symptoms not reported include hearing loss or vision problems.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Phenylketonuria (PKU): This condition is characterized by hyperphenylalaninemia, which can lead to developmental delays and hypotonia. Key symptoms not reported include seizures and behavioral issues. 
+2 Tyrosinemia: The presence of hypertyrosinemia aligns with this diagnosis, which can cause developmental delays and hypotonia. Key symptoms not reported include liver dysfunction and renal issues. 
+3 Spinal Muscular Atrophy (SMA): Generalized hypotonia and delayed development are consistent with SMA. Key symptoms not reported include muscle weakness and atrophy. 
+4 Congenital Muscular Dystrophy: This condition could explain the hypotonia and developmental delays. Key symptoms not reported include muscle weakness and joint contractures. 
+5 Maple Syrup Urine Disease (MSUD): This metabolic disorder could explain the developmental delays and hypotonia, along with metabolic abnormalities. Key symptoms not reported include distinctive urine odor and feeding difficulties.",Hereditary metabolic disorders
['Glutaryl-CoA dehydrogenase deficiency'],"+1 Glutaric Aciduria Type I: Symptoms include seizures, encephalopathy, elevated glutaric acid concentration, and opisthotonus. Key symptoms not reported include developmental delays and movement disorders. 
+2 Carnitine Palmitoyltransferase I Deficiency: Symptoms can include seizures and encephalopathy, with decreased plasma free carnitine. Key symptoms not reported include hypoketotic hypoglycemia and muscle weakness. 
+3 Organic Acidemia: Symptoms include metabolic acidosis, seizures, and encephalopathy. Key symptoms not reported include vomiting and lethargy. 
+4 Urea Cycle Disorder: Symptoms can include encephalopathy and seizures, with metabolic derangements. Key symptoms not reported include hyperammonemia and respiratory distress. 
+5 Mitochondrial Disorder: Symptoms can include seizures, encephalopathy, and metabolic abnormalities. Key symptoms not reported include exercise intolerance and myopathy.",Hereditary metabolic disorders
[],"+1: Urea Cycle Disorder: Symptoms consistent include seizures, metabolic acidosis, and hyperammonemia. Key symptoms not reported include specific neurological deficits or coma.
+2: Zellweger Spectrum Disorder: Symptoms consistent include hypotonia, seizures, hepatomegaly, and developmental delays. Key symptoms not reported include specific facial dysmorphisms or adrenal insufficiency.
+3: Mitochondrial Disorder: Symptoms consistent include hypotonia, seizures, developmental delays, and metabolic acidosis. Key symptoms not reported include exercise intolerance or myopathy.
+4: Albinism: Symptoms consistent include fair hair, strabismus, and severe hearing impairment. Key symptoms not reported include skin sensitivity to sunlight or vision problems.
+5: Pendred Syndrome: Symptoms consistent include hearing impairment and possible thyroid issues. Key symptoms not reported include goiter or specific thyroid function abnormalities.",Hereditary metabolic disorders
['PMM2-CDG'],"+1: **Cerebrotendinous xanthomatosis**: Symptoms consistent include ataxia, motor delay, hypotonia, and hepatic fibrosis. Key symptoms not reported include xanthomas and cognitive decline.
+2: **Aicardi syndrome**: Symptoms consistent include strabismus, intellectual disability, and cerebellar agenesis. Key symptoms not reported include seizures and absence of the corpus callosum.
+3: **Metachromatic leukodystrophy**: Symptoms consistent include ataxia, motor delay, and hypotonia. Key symptoms not reported include peripheral neuropathy and cognitive decline.
+4: **Alagille syndrome**: Symptoms consistent include cirrhosis and developmental delays. Key symptoms not reported include cardiac defects and eye abnormalities other than strabismus.
+5: **Bardet-Biedl syndrome**: Symptoms consistent include intellectual disability and motor delay. Key symptoms not reported include obesity, polydactyly, and renal anomalies.",Hereditary metabolic disorders
['Canavan disease'],"+1 Urea Cycle Disorder: This condition can lead to abnormal amino acid levels and neurological symptoms such as irritability and seizures. Key symptoms not reported include hyperammonemia.
+2 Non-ketotic Hyperglycinemia: This disorder is characterized by seizures, hypotonia, and irritability, aligning with the patient's symptoms. Key symptoms not reported include developmental delays.
+3 Spinal Muscular Atrophy (SMA): Presents with hypotonia and feeding difficulties, consistent with the patient's symptoms. Key symptoms not reported include progressive muscle weakness.
+4 Mitochondrial Disorder: Can cause seizures and hypotonia, consistent with the patient's presentation. Key symptoms not reported include exercise intolerance and lactic acidosis.
+5 Amino Acid Metabolism Disorder (e.g., Maple Syrup Urine Disease): This could explain the abnormal amino acid levels and neurological symptoms. Key symptoms not reported include distinctive urine odor and feeding intolerance.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Tyrosinemia: This condition is consistent with hypertyrosinemia and gastrointestinal inflammation. Key symptoms not reported include liver dysfunction and renal issues.
+2 Phenylketonuria (PKU): This diagnosis aligns with hyperphenylalaninemia. Key symptoms not reported include developmental delays and neurological impairment.
+3 Maple Syrup Urine Disease (MSUD): This condition could explain some metabolic symptoms, but lacks specific supporting symptoms like neurological signs. Key symptoms not reported include characteristic urine odor and acute metabolic crises.
+4 Congenital Disorders of Glycosylation: This could explain some developmental issues, but does not specifically account for the amino acid abnormalities. Key symptoms not reported include a range of systemic symptoms and developmental delays.
+5 Urea Cycle Disorders: While this could lead to metabolic issues, the specific amino acid abnormalities point more towards tyrosinemia or PKU. Key symptoms not reported include hyperammonemia and neurological symptoms.",Hereditary metabolic disorders
['Maple syrup urine disease'],"+1: Maple Syrup Urine Disease (MSUD): Symptoms consistent include hyperleucinemia, ataxia, and coma. Key symptoms not reported include characteristic sweet-smelling urine and developmental delays. 
+2: Urea Cycle Disorder: Symptoms consistent include metabolic acidosis and neurological symptoms. Key symptoms not reported include hyperammonemia and specific behavioral changes. 
+3: Mitochondrial Disorder: Symptoms consistent include ataxia, coma, and cerebral edema. Key symptoms not reported include exercise intolerance and myopathy. 
+4: Krabbe Disease: Symptoms consistent include ataxia, reduced tendon reflexes, and cerebral edema. Key symptoms not reported include peripheral neuropathy and developmental regression. 
+5: Adrenoleukodystrophy (ALD): Symptoms consistent include abnormal cerebral white matter morphology, ataxia, and recurrent infections. Key symptoms not reported include adrenal insufficiency and behavioral changes.",Hereditary metabolic disorders
['Acute intermittent porphyria'],"+1 Acute Intermittent Porphyria: Abdominal pain, elevated urinary ALA. Key symptoms not reported: Neurological symptoms (e.g., seizures, confusion).
+2 Hereditary Coproporphyria: Abdominal pain, elevated urinary ALA. Key symptoms not reported: Skin lesions or photosensitivity.
+3 Variegate Porphyria: Abdominal pain, elevated urinary ALA. Key symptoms not reported: Skin lesions or photosensitivity.
+4 Lead Poisoning: Abdominal pain, elevated urinary ALA. Key symptoms not reported: Neurological symptoms (e.g., cognitive impairment, peripheral neuropathy).
+5 Porphyria Cutanea Tarda: Abdominal pain. Key symptoms not reported: Skin fragility, photosensitivity, and elevated porphyrins in urine.",Hereditary metabolic disorders
['Vitamin B12-unresponsive methylmalonic acidemia'],"+1 Methylmalonic acidemia (MMA): Seizures, metabolic acidosis, methylmalonic aciduria. Key symptoms not reported: Developmental delays or failure to thrive in infancy.
+2 Propionic acidemia: Seizures, metabolic acidosis. Key symptoms not reported: Hypoglycemia and specific metabolic derangements.
+3 Organic acidemia: Seizures, metabolic acidosis. Key symptoms not reported: Varying presentations depending on the specific type of organic acidemia.
+4 Urea cycle disorder: Metabolic acidosis, seizures. Key symptoms not reported: Hyperammonemia and altered mental status.
+5 Other metabolic disorders: Seizures, metabolic acidosis. Key symptoms not reported: Symptoms vary widely depending on the specific disorder.",Hereditary metabolic disorders
['Alkaptonuria'],"+1 Urea Cycle Disorder: This condition can cause seizures, lethargy, and dark urine due to ammonia accumulation. Key symptoms not reported may include vomiting and irritability.
+2 Mitochondrial Disease: This can lead to seizures, hypotonia, and growth delays. Key symptoms not reported may include muscle weakness and exercise intolerance.
+3 Glycogen Storage Disease: This can present with hypotonia, seizures, and growth delays. Key symptoms not reported may include hepatomegaly and hypoglycemia.
+4 Maple Syrup Urine Disease: This can cause neurological symptoms and dark urine due to amino acid accumulation. Key symptoms not reported may include poor feeding and lethargy in infancy.
+5 Krabbe Disease: This can lead to hypotonia, seizures, and developmental delays. Key symptoms not reported may include irritability and loss of milestones.",Hereditary metabolic disorders
['Maple syrup urine disease'],"+1 Maple Syrup Urine Disease (MSUD): The patient exhibits seizures, aminoaciduria, and abnormal circulating levels of leucine, isoleucine, and valine. Key symptoms not reported include a characteristic sweet odor of urine and developmental delays.

+2 Urea Cycle Disorder: Seizures and metabolic derangements are consistent with this condition. However, the specific amino acid abnormalities do not align as closely. Key symptoms not reported include hyperammonemia and lethargy.

+3 Organic Acidemia: This could explain the seizures and metabolic issues, but the specific amino acid profile is more indicative of MSUD. Key symptoms not reported include metabolic acidosis and failure to thrive.

+4 Glutaric Acidemia: This condition can present with seizures and abnormal amino acid levels, but the specific profile of leucine, isoleucine, and valine is more characteristic of MSUD. Key symptoms not reported include movement disorders and macrocephaly.

+5 Phenylketonuria (PKU): While seizures can occur, the primary issue in PKU is phenylalanine accumulation, not the branched-chain amino acids. Key symptoms not reported include intellectual disability and a musty odor in urine.",Hereditary metabolic disorders
['Very long chain acyl-CoA dehydrogenase deficiency'],"+1 Carnitine Palmitoyltransferase II Deficiency (CPT II Deficiency): This condition is consistent with hypoglycemia, cardiomegaly, increased lactate, and dicarboxylic aciduria. Key symptoms not reported include muscle weakness and exercise intolerance. 
+2 Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCADD): This diagnosis aligns with hypoglycemia, increased lactate, and dicarboxylic aciduria. Key symptoms not reported include vomiting and lethargy during fasting. 
+3 Mitochondrial Myopathy: This could explain cardiomegaly and increased lactate. Key symptoms not reported include muscle pain and exercise intolerance. 
+4 Glycogen Storage Disease (GSD): Certain types could explain cardiomyopathy and hypoglycemia. Key symptoms not reported include hepatomegaly and growth retardation. 
+5 Organic Acidemia (e.g., Propionic Acidemia): This could explain increased lactate and dicarboxylic aciduria. Key symptoms not reported include metabolic acidosis and developmental delays.",Hereditary metabolic disorders
['3-hydroxy-3-methylglutaric aciduria'],"+1 Glutaric acidemia type I: Symptoms consistent with this diagnosis include glutaric aciduria, progressive neurological deterioration, and seizures. Key symptoms not reported include movement disorders and macrocephaly. 
+2 3-Methylglutaconic aciduria: Symptoms consistent with this diagnosis include 3-methylglutaric aciduria, lethargy, and seizures. Key symptoms not reported include sensorineural hearing loss and muscle weakness. 
+3 Non-ketotic hyperglycinemia: Symptoms consistent with this diagnosis include abnormal circulating glycine concentration, seizures, and lethargy. Key symptoms not reported include hypotonia and developmental delay. 
+4 Urea cycle disorder: Symptoms consistent with this diagnosis include metabolic acidosis, hypoglycemia, and neurological symptoms. Key symptoms not reported include hyperammonemia and specific amino acid imbalances. 
+5 Mitochondrial disorder: Symptoms consistent with this diagnosis include lethargy, seizures, and progressive neurological deterioration. Key symptoms not reported include exercise intolerance and myopathy.",Hereditary metabolic disorders
['MODY'],"+1 Insulinoma: This condition could explain the hypoglycemia due to excess insulin secretion. The glycosuria may not be directly related unless there is concurrent diabetes. Key symptoms not reported include episodes of confusion, sweating, or palpitations during hypoglycemic events. 
+2 Diabetes Mellitus: This could explain the glycosuria due to elevated blood glucose levels. The hypoglycemia could occur if the patient is on insulin or other medications. Key symptoms not reported include increased thirst, frequent urination, and fatigue. 
+3 Adrenal Insufficiency: This could lead to hypoglycemia due to low cortisol levels. Glycosuria is less common but could occur with concurrent diabetes. Key symptoms not reported include fatigue, weight loss, and hyperpigmentation. 
+4 Porphyria: The abnormal porphyrin levels suggest a porphyria, which can have various metabolic implications. However, it does not typically present with hypoglycemia or glycosuria. Key symptoms not reported include abdominal pain, photosensitivity, and neurological symptoms. 
+5 Renal Glycosuria: This condition can cause glycosuria without hyperglycemia, but it does not explain the hypoglycemia or abnormal porphyrin levels. Key symptoms not reported include any signs of diabetes or metabolic syndrome.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Phenylketonuria (PKU): This condition is characterized by hyperphenylalaninemia and can lead to severe developmental issues and neonatal death. Symptoms consistent with this diagnosis include hyperphenylalaninemia and death in infancy. Key symptoms not reported include developmental delays if the infant had survived longer.
+2 Congenital heart defects: These can lead to neonatal death and may be associated with prenatal development abnormalities. Symptoms consistent with this diagnosis include death in infancy and abnormality of prenatal development. Key symptoms not reported include specific cardiac symptoms or signs of heart failure.
+3 Metabolic disorders (other than PKU): Other metabolic disorders could lead to similar outcomes. Symptoms consistent with this diagnosis include hyperphenylalaninemia and death in infancy. Key symptoms not reported include specific metabolic derangements or other enzyme deficiencies.
+4 Genetic syndromes: Certain genetic conditions can lead to both developmental issues and metabolic problems. Symptoms consistent with this diagnosis include abnormality of prenatal development and death in infancy. Key symptoms not reported include specific phenotypic features associated with known syndromes.
+5 Infections during pregnancy: Infections can lead to developmental issues and neonatal death. Symptoms consistent with this diagnosis include abnormality of prenatal development and death in infancy. Key symptoms not reported include maternal symptoms during pregnancy or specific signs of congenital infection in the infant.",Hereditary metabolic disorders
['Glutaryl-CoA dehydrogenase deficiency'],"+1 Glutaric Aciduria: Symptoms consistent include hydrocephalus, macrocephaly, seizures, and hyperreflexia. Key symptoms not reported include developmental delays and specific metabolic crises.
+2 Metachromatic Leukodystrophy: Symptoms consistent include seizures, lethargy, and hyperreflexia. Key symptoms not reported include loss of motor skills and speech.
+3 Krabbe Disease: Symptoms consistent include seizures, lethargy, and hyperreflexia. Key symptoms not reported include irritability and developmental regression.
+4 Mitochondrial Encephalomyopathy: Symptoms consistent include seizures, lethargy, and increased CSF protein concentration. Key symptoms not reported include muscle weakness and exercise intolerance.
+5 Cerebral Palsy: Symptoms consistent include dystonia, hyperreflexia, and opisthotonus. Key symptoms not reported include spasticity and motor function impairment.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Tyrosinemia: This condition is consistent with hypertyrosinemia and can lead to severe complications, including death in infancy. Key symptoms not reported include liver dysfunction and neurological symptoms.

+2 Phenylketonuria (PKU): Hyperphenylalaninemia aligns with this diagnosis, which can lead to developmental issues and death if untreated. Key symptoms not reported include intellectual disability and seizures.

+3 Maple Syrup Urine Disease (MSUD): While not directly linked to the reported amino acid abnormalities, it can cause severe outcomes in infancy. Key symptoms not reported include characteristic sweet-smelling urine and neurological decline.

+4 Urea Cycle Disorders: These can lead to severe neurological damage and death in infancy. Key symptoms not reported include hyperammonemia and lethargy.

+5 Congenital Disorders of Glycosylation: These can present with developmental delays and organ dysfunction. Key symptoms not reported include failure to thrive and various systemic manifestations.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Tyrosinemia Type I: This condition is consistent with hypertyrosinemia and could explain the early mortality. Key symptoms not reported include liver failure and neurological symptoms.

+2 Phenylketonuria (PKU): This aligns with hyperphenylalaninemia and could lead to severe neurological impairment. Key symptoms not reported include developmental delays and intellectual disability.

+3 Urea Cycle Disorders: These can cause elevated levels of amino acids and lead to metabolic crises. Key symptoms not reported include hyperammonemia and neurological symptoms.

+4 Maple Syrup Urine Disease (MSUD): This disorder can present with elevated amino acids and neurological symptoms. Key symptoms not reported include sweet-smelling urine and developmental delays.

+5 Liver Disease: Underlying liver dysfunction could explain hypertyrosinemia and early mortality. Key symptoms not reported include jaundice and abdominal pain.",Hereditary metabolic disorders
['Phenylketonuria'],"<thinking> 
The patient presents with a complex set of symptoms that suggest a serious metabolic disorder, particularly involving amino acid metabolism. Key symptoms include:

- Abnormality of prenatal development or birth
- Death in infancy
- Hypertyrosinemia
- Neonatal death
- Hyperphenylalaninemia
- Elevated urinary carboxylic acid
- Death in early adulthood

The combination of hypertyrosinemia and hyperphenylalaninemia indicates a potential issue with the metabolism of tyrosine and phenylalanine, which are amino acids. These conditions are often associated with genetic disorders that affect enzyme function, leading to toxic accumulation of metabolites.

Possible diagnoses include:

1. **Phenylketonuria (PKU)**: This condition is characterized by hyperphenylalaninemia due to a deficiency in the enzyme phenylalanine hydroxylase. The patient’s symptoms of neonatal death and abnormal prenatal development could align with untreated PKU, which can lead to severe neurological damage if not managed early. However, the presence of hypertyrosinemia suggests that PKU alone may not fully explain the clinical picture.

2. **Tyrosinemia**: This condition involves elevated levels of tyrosine and can lead to severe complications, including liver failure and neurological issues. The presence of hypertyrosinemia and elevated urinary carboxylic acid supports this diagnosis. The neonatal death and early adulthood death could be outcomes of severe forms of tyrosinemia, particularly type I.

3. **Maple Syrup Urine Disease (MSUD)**: This disorder is characterized by elevated branched-chain amino acids and could potentially explain some of the symptoms, particularly the elevated urinary carboxylic acid. However, it does not directly account for the hyperphenylalaninemia or hypertyrosinemia.

4. **Urea Cycle Disorders**: These disorders can lead to elevated ammonia levels and various metabolic derangements. While they could explain some symptoms, they do not specifically account for the hyperphenylalaninemia or hypertyrosinemia.

5. **Organic Acidemias**: Conditions such as propionic acidemia or methylmalonic acidemia could lead to elevated urinary carboxylic acids and metabolic crises, but they do not directly explain the hyperphenylalaninemia or hypertyrosinemia.

To narrow down the diagnosis, additional tests could include:

- Genetic testing for known metabolic disorders
- Plasma amino acid analysis to quantify levels of phenylalanine, tyrosine, and other amino acids
- Urine organic acid analysis to identify specific organic acids present
- Liver function tests to assess for any hepatic involvement

Overall, the combination of symptoms suggests a serious metabolic disorder, likely involving both phenylalanine and tyrosine metabolism. 

</thinking>

<top5> 
+1 Tyrosinemia: This condition is consistent with hypertyrosinemia and elevated urinary carboxylic acid. Key symptoms not reported include liver dysfunction and renal issues. 
+2 Phenylketonuria (PKU): Consistent with hyperphenylalaninemia and abnormal prenatal development. Key symptoms not reported include neurological deficits if untreated. 
+3 Maple Syrup Urine Disease (MSUD): Elevated urinary carboxylic acid may align, but does not explain hyperphenylalaninemia or hypertyrosinemia. Key symptoms not reported include characteristic sweet-smelling urine and neurological symptoms. 
+4 Urea Cycle Disorders: Could explain some metabolic derangements but does not specifically account for the hyperphenylalaninemia or hypertyrosinemia. Key symptoms not reported include hyperammonemia and associated neurological symptoms. 
+5 Organic Acidemias: Elevated urinary carboxylic acids align, but do not explain the other amino acid abnormalities. Key symptoms not reported include metabolic acidosis and failure to thrive. 
</top5",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Phenylketonuria (PKU): Hyperphenylalaninemia, abnormality of prenatal development. Key symptoms not reported: Intellectual disability, seizures.
+2 Tyrosinemia: Hypertyrosinemia, neonatal death, abnormality of prenatal development. Key symptoms not reported: Liver dysfunction, failure to thrive.
+3 Maple Syrup Urine Disease (MSUD): Abnormality of prenatal development, death in infancy. Key symptoms not reported: Sweet-smelling urine, neurological symptoms.
+4 Urea Cycle Disorders: Death in infancy, abnormality of prenatal development. Key symptoms not reported: Hyperammonemia, lethargy.
+5 Congenital Disorders of Glycosylation (CDG): Abnormality of prenatal development, death in childhood. Key symptoms not reported: Multisystem involvement, developmental delays.",Hereditary metabolic disorders
['Hereditary orotic aciduria'],"+1 Urea Cycle Disorder: Symptoms consistent include hyperglycinuria, ornithinuria, lethargy, and hypotonia. Key symptoms not reported include severe neurological deficits or seizures.
+2 Lysosomal Storage Disease: Symptoms consistent include splenomegaly, hepatomegaly, and generalized hypotonia. Key symptoms not reported include specific neurological decline or skeletal abnormalities.
+3 Mitochondrial Disorder: Symptoms consistent include lethargy, hypotonia, and organomegaly. Key symptoms not reported include exercise intolerance or specific neurological symptoms.
+4 Inborn Errors of Metabolism: Symptoms consistent include metabolic abnormalities (e.g., orotic aciduria, cystinuria) and lethargy. Key symptoms not reported include specific dietary intolerances or acute metabolic crises.
+5 Infectious Disease/Autoimmune Condition: Symptoms consistent include fever, rash, and pneumonia. Key symptoms not reported include chronic infections or autoimmune markers.",Hereditary metabolic disorders
['Holocarboxylase synthetase deficiency'],"+1 Propionic Acidemia: Symptoms include metabolic acidosis, hypotonia, hyperammonemia, and aminoaciduria. Key symptoms not reported include developmental delays and seizures. 
+2 Methylmalonic Acidemia: Symptoms include metabolic acidosis, hypotonia, and developmental delays. Key symptoms not reported include specific neurological deficits and failure to thrive. 
+3 Urea Cycle Disorder: Symptoms include hyperammonemia and metabolic acidosis. Key symptoms not reported include lethargy and vomiting. 
+4 Organic Acidemia: Symptoms include metabolic acidosis and hypotonia. Key symptoms not reported include specific organic acid accumulation symptoms. 
+5 Aminoacidopathy: Symptoms include aminoaciduria and metabolic disturbances. Key symptoms not reported include specific amino acid-related symptoms such as growth retardation.",Hereditary metabolic disorders
['Ornithine transcarbamylase deficiency'],"<thinking> 
The patient presents with a combination of symptoms that are quite concerning and suggest a metabolic or neurological disorder. Key symptoms include:

- **Apathy**: This could indicate a central nervous system issue or metabolic dysfunction.
- **Ataxia**: This suggests a problem with coordination, often linked to cerebellar dysfunction or metabolic disorders.
- **Lethargy and Drowsiness**: These symptoms point towards a significant level of fatigue or altered mental status, which can be seen in various conditions, including metabolic disorders.
- **Hyperammonemia**: Elevated ammonia levels are particularly indicative of urea cycle disorders or liver dysfunction, which can lead to neurological symptoms.
- **Vomiting**: This can be a result of increased intracranial pressure or metabolic disturbances.
- **Sleep abnormality**: This could be related to neurological issues or metabolic imbalances.
- **Orotic aciduria**: The presence of orotic acid in urine is often associated with urea cycle disorders or certain types of metabolic disorders.
- **Death in adolescence**: This is a critical factor that suggests a severe, progressive condition that typically manifests in childhood or adolescence.

Given these symptoms, several potential diagnoses come to mind:

1. **Urea Cycle Disorder (UCD)**: The combination of hyperammonemia and orotic aciduria strongly suggests a urea cycle disorder, such as Ornithine Transcarbamylase Deficiency. This condition leads to the accumulation of ammonia in the blood, which can cause neurological symptoms and is often fatal if untreated.

2. **Maple Syrup Urine Disease (MSUD)**: This metabolic disorder can present with lethargy, vomiting, and neurological symptoms. However, orotic aciduria is not typically associated with MSUD, making it a less likely diagnosis.

3. **Cerebral Urea Cycle Disorder**: This is a specific type of UCD that can lead to neurological symptoms and is characterized by hyperammonemia. The presence of ataxia and drowsiness aligns with this diagnosis.

4. **Mitochondrial Encephalomyopathy**: Conditions like MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes) could present with ataxia, lethargy, and neurological decline, but hyperammonemia and orotic aciduria are not typical findings.

5. **Amino Acid Metabolism Disorder**: Disorders such as Argininosuccinic aciduria could present with similar symptoms, but the specific combination of hyperammonemia and orotic aciduria points more towards a urea cycle disorder.

To narrow down the diagnosis, additional tests could include:

- Genetic testing for known urea cycle disorders.
- Liver function tests to assess for hepatic dysfunction.
- Plasma amino acid analysis to look for specific metabolic derangements.
- MRI of the brain to evaluate for any structural abnormalities.

Overall, the combination of symptoms strongly suggests a metabolic disorder, particularly a urea cycle disorder, which should be prioritized in further evaluation.
</thinking>

<top5>
+1 Urea Cycle Disorder: Hyperammonemia, Orotic aciduria, Ataxia, Lethargy, Drowsiness. Key symptoms not reported: None.
+2 Cerebral Urea Cycle Disorder: Hyperammonemia, Ataxia, Lethargy, Drowsiness. Key symptoms not reported: None.
+3 Maple Syrup Urine Disease: Lethargy, Vomiting, Drowsiness. Key symptoms not reported: Orotic aciduria, Hyperammonemia.
+4 Mitochondrial Encephalomyopathy: Ataxia, Lethargy, Drowsiness. Key symptoms not reported: Hyperammonemia, Orotic aciduria.
+5 Amino Acid Metabolism Disorder: Hyperammonemia, Ataxia,",Hereditary metabolic disorders
[],"+1 Ethylmalonic Encephalopathy: This condition is consistent with ethylmalonic aciduria, vomiting, and the history of early death. Key symptoms not reported include neurological deficits and developmental delays.
+2 Carnitine Palmitoyltransferase II Deficiency: This diagnosis aligns with abnormal carnitine levels and metabolic crises. Key symptoms not reported include hypoketotic hypoglycemia and muscle weakness.
+3 Short-Chain Acyl-CoA Dehydrogenase Deficiency: This could explain the decreased enzyme levels but does not typically present with ethylmalonic aciduria. Key symptoms not reported include episodes of metabolic decompensation.
+4 Medium-Chain Acyl-CoA Dehydrogenase Deficiency: This condition could lead to similar symptoms but typically does not present with ethylmalonic aciduria. Key symptoms not reported include hypoglycemia and lethargy during fasting.
+5 Mitochondrial Disorder: This broad category could explain the combination of symptoms but requires further testing for confirmation. Key symptoms not reported include exercise intolerance and myopathy.",Hereditary metabolic disorders
['Smith-Lemli-Opitz syndrome'],"+1 Smith-Lemli-Opitz Syndrome: This condition is characterized by low cholesterol levels, elevated 7-dehydrocholesterol, and physical anomalies such as low-set ears and syndactyly. Key symptoms not reported include cardiac defects and genital anomalies.

+2 Down Syndrome: This syndrome can present with low-set ears and hypotonia, but does not typically feature the specific metabolic abnormalities noted. Key symptoms not reported include distinct facial features such as a flat facial profile and slanted eyes.

+3 Cornelia de Lange Syndrome: This syndrome includes features like low-set ears and developmental delays, but the metabolic profile does not align. Key symptoms not reported include limb malformations and facial dysmorphism.

+4 Zellweger Syndrome: This peroxisomal disorder can present with hypotonia and developmental delays, but the specific cholesterol abnormalities are not typical. Key symptoms not reported include liver dysfunction and vision problems.

+5 Other congenital syndromes with syndactyly: Various syndromes can present with syndactyly and developmental delays, but the specific metabolic findings suggest a more defined condition. Key symptoms not reported vary widely depending on the specific syndrome.",Hereditary metabolic disorders
['L-2-hydroxyglutaric aciduria'],"+1 L-2-hydroxyglutaric aciduria: This diagnosis is consistent with the presence of L-2-hydroxyglutaric aciduria, intellectual disability, ataxia, and tremor. Key symptoms not reported include seizures, which can occur in some cases.
+2 Glutaric aciduria type I: This condition aligns with the neurological symptoms and abnormal basal ganglia morphology. Key symptoms not reported include macrocephaly and movement disorders.
+3 Mitochondrial disorders: These can cause ataxia and intellectual disability, but would require further metabolic testing. Key symptoms not reported include myopathy or exercise intolerance.
+4 Other genetic syndromes: While conditions like Rett syndrome could fit some symptoms, they do not explain the metabolic finding. Key symptoms not reported include hand-wringing movements or loss of purposeful hand skills.
+5 Peroxisomal disorders: These can lead to developmental delays and neurological symptoms, but the specific metabolic profile points more towards L-2-hydroxyglutaric aciduria. Key symptoms not reported include vision or hearing loss, which can occur in some peroxisomal disorders.",Hereditary metabolic disorders
['3-hydroxy-3-methylglutaric aciduria'],"+1 Organic Acidemia: Symptoms consistent include metabolic acidosis, irritability, seizures, and dicarboxylic aciduria. Key symptoms not reported may include vomiting and failure to thrive.

+2 Mitochondrial Disorder: Symptoms consistent include generalized hypotonia, seizures, metabolic acidosis, and 3-methylglutaconic aciduria. Key symptoms not reported may include developmental delays and muscle weakness.

+3 Urea Cycle Disorder: Symptoms consistent include irritability and metabolic acidosis. Key symptoms not reported may include hyperammonemia and lethargy.

+4 Fatty Acid Oxidation Disorder: Symptoms consistent include metabolic acidosis and dicarboxylic aciduria. Key symptoms not reported may include hypoglycemia and cardiomyopathy.

+5 Peroxisomal Disorders: Symptoms consistent include generalized hypotonia, seizures, and early mortality. Key symptoms not reported may include dysmorphic features and liver dysfunction.",Hereditary metabolic disorders
['L-2-hydroxyglutaric aciduria'],"+1 L-2-hydroxyglutaric aciduria: This diagnosis is supported by the presence of L-2-hydroxyglutaric aciduria and seizures. Key symptoms not reported include developmental delays or cognitive impairment. 
+2 Genetic syndromes (e.g., mitochondrial disorders): The combination of symptoms, including death in infancy and neurological issues, suggests a possible genetic disorder. Key symptoms not reported may include muscle weakness or exercise intolerance. 
+3 Infection (e.g., viral encephalitis): The fever and seizures could indicate an infectious process. Key symptoms not reported may include altered consciousness or focal neurological deficits. 
+4 Eczematoid dermatitis: This skin condition is present but does not explain the neurological symptoms. Key symptoms not reported may include itching or chronic skin lesions. 
+5 Iron deficiency anemia: The decreased circulating iron concentration suggests anemia, which can cause fatigue and neurological symptoms. Key symptoms not reported may include pallor or fatigue.",Hereditary metabolic disorders
['X-linked hypophosphatemia'],"+1 X-linked hypophosphatemic rickets (XLH): This condition aligns with hypophosphatemia, abnormal limb bone morphology, and elevated alkaline phosphatase. Key symptoms not reported include dental issues and potential growth retardation.
+2 Fanconi syndrome: This disorder could explain nephritis and hypophosphatemia, along with bone abnormalities. Key symptoms not reported include glucosuria and aminoaciduria.
+3 Cystinosis: This condition may lead to renal failure and bone issues, consistent with nephritis and abnormal bone morphology. Key symptoms not reported include ocular symptoms and growth failure.
+4 Hypophosphatasia: While this condition typically presents with low alkaline phosphatase, the elevated levels in this case suggest a different pathology. Key symptoms not reported include early loss of teeth and skeletal deformities.
+5 Osteogenesis imperfecta: This condition could explain abnormal limb bone morphology but does not typically present with nephritis or hypophosphatemia. Key symptoms not reported include frequent fractures and blue sclera.",Hereditary metabolic disorders
['Propionic acidemia'],"+1 Non-ketotic hyperglycinemia: Consistent with hyperglycinemia, delayed speech and language development. Key symptoms not reported include seizures and hypotonia.
+2 Urea cycle disorder (e.g., Ornithine transcarbamylase deficiency): Consistent with hyperammonemia, leukopenia, and developmental delays. Key symptoms not reported include acute neurological symptoms and specific metabolic crises.
+3 Glycine encephalopathy: Consistent with hyperglycinemia and developmental delays. Key symptoms not reported include seizures and specific neurological deficits.
+4 Organic acidemia (e.g., propionic acidemia): Consistent with elevated urinary carboxylic acid and amino acid abnormalities. Key symptoms not reported include metabolic acidosis and specific neurological symptoms.
+5 Maple syrup urine disease: Consistent with some amino acid abnormalities. Key symptoms not reported include characteristic odor and acute neurological symptoms.",Hereditary metabolic disorders
"['Methylmalonic acidemia with homocystinuria, type cblC']","+1 Homocystinuria: This condition is characterized by hyperhomocystinemia and can lead to developmental delays and neurological symptoms. Key symptoms not reported include lens dislocation and thromboembolic events. 
+2 Methylmalonic acidemia: The presence of methylmalonic aciduria aligns with this diagnosis, which can cause hypotonia and developmental delays. Key symptoms not reported include metabolic crises and failure to thrive.
+3 Organic acidemia: This broad category includes several disorders that could explain the metabolic derangements and developmental issues. Key symptoms not reported include episodic vomiting and metabolic acidosis.
+4 Peroxisomal disorders: These can present with hypotonia and developmental delays, but the specific metabolic findings do not typically align. Key symptoms not reported include seizures and vision problems.
+5 Urea cycle disorders: These can lead to neurological symptoms and developmental delays but are less likely given the specific metabolic findings. Key symptoms not reported include hyperammonemia and lethargy.",Hereditary metabolic disorders
['Biotinidase deficiency'],"+1 Organic Acidemia: Elevated urinary carboxylic acid levels are consistent with this diagnosis. Key symptoms not reported may include metabolic acidosis and neurological symptoms.
+2 Fatty Acid Oxidation Disorder: Elevated urinary carboxylic acids can indicate this condition. Key symptoms not reported may include hypoglycemia and lethargy.
+3 Urea Cycle Disorder: While not directly indicated by the urinary findings, the history of neonatal death raises concern. Key symptoms not reported may include hyperammonemia and altered mental status.
+4 Mitochondrial Disorder: Elevated carboxylic acids may suggest mitochondrial dysfunction. Key symptoms not reported may include muscle weakness and developmental delays.
+5 Genetic Syndrome (e.g., Zellweger Syndrome): The combination of symptoms could suggest a genetic syndrome. Key symptoms not reported may include dysmorphic features and organ dysfunction.",Hereditary metabolic disorders
['Carbamoyl-phosphate synthetase 1 deficiency'],"+1 Urea Cycle Disorder: Symptoms include hyperammonemia, lethargy, feeding difficulties, and neurological symptoms such as hypotonia and hyperreflexia. Key symptoms not reported include seizures or vomiting.
+2 Maple Syrup Urine Disease: Characterized by lethargy, hypotonia, and feeding difficulties, along with metabolic derangements. Key symptoms not reported include a distinctive sweet odor in urine and neurological decline.
+3 Organic Acidemia: Symptoms can include lethargy, hypotonia, and metabolic crises leading to hyperammonemia. Key symptoms not reported include acidosis and specific metabolic derangements in urine.
+4 Spinal Muscular Atrophy: Presents with hypotonia and feeding difficulties, but typically does not cause hyperammonemia. Key symptoms not reported include muscle weakness and atrophy.
+5 Mitochondrial Disorder: Can present with lethargy, hypotonia, and neurological symptoms. Key symptoms not reported include exercise intolerance and specific organ involvement (e.g., cardiomyopathy).",Hereditary metabolic disorders
['Vitamin B12-unresponsive methylmalonic acidemia'],"+1 Methylmalonic Acidemia: Symptoms include metabolic acidosis and decreased methylmalonyl-CoA mutase activity. Key symptoms not reported include developmental delays and failure to thrive in infancy. 
+2 Propionic Acidemia: Symptoms include metabolic acidosis and can lead to similar outcomes. Key symptoms not reported include hypoglycemia and ketonuria. 
+3 Isovaleric Acidemia: Symptoms include metabolic acidosis and can present similarly. Key symptoms not reported include a characteristic ""sweaty feet"" odor and acute metabolic crises. 
+4 Urea Cycle Disorder: Symptoms include metabolic acidosis and can lead to severe outcomes. Key symptoms not reported include hyperammonemia and neurological symptoms. 
+5 Glutaric Acidemia: Symptoms include metabolic acidosis and can lead to neurological issues. Key symptoms not reported include movement disorders and macrocephaly.",Hereditary metabolic disorders
[],"+1 Galactosemia: This condition is consistent with hemolytic anemia, metabolic acidosis, and increased bilirubin. Key symptoms not reported include failure to thrive and liver dysfunction.
+2 Porphyria: The abnormal circulating porphyrin concentration aligns with this diagnosis, along with hemolytic anemia. Key symptoms not reported include photosensitivity and abdominal pain.
+3 Sickle Cell Disease: This could explain the hemolytic anemia and increased lactate dehydrogenase. Key symptoms not reported include pain crises and dactylitis.
+4 Severe Combined Immunodeficiency (SCID): The recurrent viral infections are consistent with this diagnosis. Key symptoms not reported include failure to thrive and opportunistic infections.
+5 Urea Cycle Disorder: This could account for metabolic acidosis and neurological symptoms. Key symptoms not reported include hyperammonemia and altered mental status.",Hereditary metabolic disorders
['Neonatal intrahepatic cholestasis due to citrin deficiency'],"+1 Citrullinemia: Symptoms include hyperammonemia, elevated plasma citrulline, respiratory distress, and apnea. Key symptoms not reported include neurological symptoms such as lethargy or seizures. 
+2 Ornithine Transcarbamylase Deficiency: Symptoms include hyperammonemia, respiratory distress, and apnea. Key symptoms not reported include specific neurological deficits or seizures. 
+3 Mitochondrial Disorder: Symptoms may include respiratory distress and metabolic crises. Key symptoms not reported include muscle weakness or developmental delays. 
+4 Sepsis: Symptoms include respiratory distress and hypoxemia. Key symptoms not reported include fever or signs of infection. 
+5 Congenital Heart Defect: Symptoms include hypoxemia and respiratory distress. Key symptoms not reported include cyanosis or heart murmur.",Hereditary metabolic disorders
[],"+1 Methylmalonic Acidemia (MMA): Symptoms consistent include hyperammonemia, vomiting, seizures, hypotonia, and intellectual disability. Key symptoms not reported may include specific metabolic crises or episodes of acidosis.

+2 Urea Cycle Disorder: Symptoms consistent include hyperammonemia, seizures, and intellectual disability. Key symptoms not reported may include specific amino acid imbalances or metabolic crises.

+3 Organic Acidemia: Symptoms consistent include increased circulating lactate concentration and neurological symptoms. Key symptoms not reported may include specific organic acid profiles.

+4 Atransferrinemia: Symptoms consistent include anemia and leukopenia. Key symptoms not reported may include iron overload symptoms or specific transferrin levels.

+5 Chronic Kidney Disease (CKD): Symptoms consistent include acute kidney injury and hypertension. Key symptoms not reported may include specific electrolyte imbalances or renal function tests.",Hereditary metabolic disorders
['Dihydropteridine reductase deficiency'],"+1 Phenylketonuria (PKU): Symptoms consistent include intellectual disability, seizures, and motor delay. Key symptoms not reported include a specific diet history or phenylalanine levels.
+2 Tyrosinemia: Symptoms consistent include hypertyrosinemia, intellectual disability, and seizures. Key symptoms not reported include liver dysfunction or specific dietary restrictions.
+3 Congenital Zika Syndrome: Symptoms consistent include microcephaly and developmental delays. Key symptoms not reported include maternal history of Zika virus infection.
+4 Lissencephaly: Symptoms consistent include microcephaly, seizures, and developmental delays. Key symptoms not reported include specific imaging findings of the brain.
+5 Aicardi Syndrome: Symptoms consistent include microcephaly, nystagmus, and seizures. Key symptoms not reported include the presence of other associated anomalies or family history.",Hereditary metabolic disorders
[],"+1 Mitochondrial myopathy: The presence of cytochrome C oxidase-negative muscle fibers and ethylmalonic aciduria are consistent with this diagnosis. Key symptoms not reported include muscle weakness and exercise intolerance.
+2 Organic acidemia: Ethylmalonic aciduria aligns with this diagnosis, and feeding difficulties are common. Key symptoms not reported include metabolic acidosis and developmental delays.
+3 Glycine encephalopathy: Abnormal circulating glycine concentration supports this diagnosis, but the skin rash is atypical. Key symptoms not reported include seizures and neurological deficits.
+4 Urea cycle disorder: Abnormal glycine levels could suggest this condition, and feeding difficulties are common. Key symptoms not reported include hyperammonemia and lethargy.
+5 Inherited metabolic disorder: The combination of symptoms, particularly infant mortality and metabolic derangements, suggests this broader category. Key symptoms not reported include specific metabolic crises or developmental delays.",Hereditary metabolic disorders
['Carbamoyl-phosphate synthetase 1 deficiency'],"+1 Urea Cycle Disorder (Ornithine Transcarbamylase Deficiency): Symptoms consistent include hyperammonemia, orotic aciduria, low plasma citrulline, and seizures. Key symptoms not reported may include specific neurological deficits or developmental delays.
+2 Citrullinemia: Symptoms consistent include hyperammonemia, low plasma citrulline, and seizures. Key symptoms not reported may include elevated citrulline levels in urine and specific neurological symptoms.
+3 Argininosuccinic Aciduria: Symptoms consistent include hyperammonemia and seizures. Key symptoms not reported may include elevated levels of argininosuccinic acid in urine and potential developmental delays.
+4 Hyperargininemia: Symptoms consistent include hypoargininemia and seizures. Key symptoms not reported may include specific neurological deficits and developmental issues.
+5 Mitochondrial Disorders: Symptoms consistent include seizures and cerebral edema. Key symptoms not reported may include muscle weakness and other systemic symptoms related to mitochondrial dysfunction.",Hereditary metabolic disorders
['Canavan disease'],"+1 Urea Cycle Disorder: Symptoms include hyperammonemia, seizures, and potential neonatal death. Key symptoms not reported include lethargy and vomiting. 
+2 Non-ketotic Hyperglycinemia: Characterized by elevated glycine levels, seizures, and neurological impairment. Key symptoms not reported include hypotonia and developmental delays. 
+3 Maple Syrup Urine Disease: Presents with aminoaciduria and neurological symptoms. Key symptoms not reported include a characteristic sweet odor in urine and feeding difficulties. 
+4 Phenylketonuria (PKU): Involves aminoaciduria and can lead to neurological symptoms. Key symptoms not reported include intellectual disability and a musty odor in urine. 
+5 Glycine Encephalopathy: Associated with elevated glycine levels, seizures, and skin manifestations. Key symptoms not reported include severe developmental delays and hypotonia.",Hereditary metabolic disorders
['Maple syrup urine disease'],"+1 Maple Syrup Urine Disease (MSUD): This condition is consistent with hypervalinemia, hyperleucinemia, and hyperisoleucinemia, as well as seizures and feeding difficulties. Key symptoms not reported include a characteristic sweet odor of urine.

+2 Urea Cycle Disorder: This could explain seizures and respiratory insufficiency, but the specific amino acid profile does not align with classic presentations. Key symptoms not reported include lethargy and vomiting.

+3 Non-ketotic Hyperglycinemia: This condition can cause seizures and respiratory issues, but the amino acid abnormalities do not support this diagnosis. Key symptoms not reported include hypotonia and developmental delay.

+4 Sepsis due to metabolic disorder: Sepsis could be a complication of an underlying metabolic disorder, but it does not explain the neurological symptoms directly. Key symptoms not reported include fever and signs of infection.

+5 Congenital disorders of glycosylation: These can present with seizures and feeding difficulties, but the specific amino acid abnormalities do not directly correlate. Key symptoms not reported include failure to thrive and developmental delays.",Hereditary metabolic disorders
['Medium chain acyl-CoA dehydrogenase deficiency'],"+1 Carnitine Palmitoyltransferase II Deficiency (CPT II Deficiency): This condition is consistent with abnormal circulating carnitine concentration and decreased 3-hydroxyacyl-CoA dehydrogenase levels. Key symptoms not reported include episodes of hypoglycemia and muscle weakness.
+2 Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCADD): The decreased 3-hydroxyacyl-CoA dehydrogenase level aligns with this diagnosis. Key symptoms not reported include hypoglycemia and metabolic crises.
+3 Congenital Disorders of Glycosylation (CDG): The obesity and developmental abnormalities are consistent with this diagnosis. Key symptoms not reported include neurological deficits and coagulopathy.
+4 Mitochondrial Disorders: The obesity and metabolic dysfunction could suggest this condition. Key symptoms not reported include exercise intolerance and lactic acidosis.
+5 Prader-Willi Syndrome: The obesity and developmental delays align with this diagnosis. Key symptoms not reported include hypotonia and behavioral issues.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Tyrosinemia: Symptoms consistent include hypertyrosinemia, intellectual disability, seizures, and motor delay. Key symptoms not reported include liver dysfunction and renal issues.
+2 Phenylketonuria (PKU): Symptoms consistent include hyperphenylalaninemia and intellectual disability. Key symptoms not reported include a musty odor in urine and skin rashes.
+3 Metachromatic leukodystrophy: Symptoms consistent include intellectual disability, seizures, motor delay, and abnormal cerebral white matter morphology. Key symptoms not reported include progressive loss of motor skills and speech.
+4 Krabbe disease: Symptoms consistent include motor delay, dyskinesia, and seizures. Key symptoms not reported include irritability and loss of vision.
+5 Alexander disease: Symptoms consistent include intellectual disability, seizures, and abnormal cerebral white matter morphology. Key symptoms not reported include macrocephaly and developmental regression.",Hereditary metabolic disorders
['Wilson disease'],"+1 Wilson's disease: Symptoms include hepatomegaly, splenomegaly, decreased ceruloplasmin, and increased urinary copper concentration. Key symptoms not reported include neurological symptoms such as tremors or psychiatric disturbances. 
+2 Menkes disease: Symptoms include hypotonia and copper deficiency, but the presence of hepatomegaly and splenomegaly makes this less likely. Key symptoms not reported include kinky hair and developmental delays. 
+3 Niemann-Pick disease: Symptoms include splenomegaly and hepatomegaly, but the copper-related findings are atypical. Key symptoms not reported include neurological decline and cherry-red spot on the retina. 
+4 Gaucher's disease: Symptoms include splenomegaly and hepatomegaly, but the copper accumulation is not characteristic. Key symptoms not reported include bone pain and anemia. 
+5 Alpha-1 antitrypsin deficiency: Symptoms include liver disease and hypotonia, but the copper-related findings are not typical. Key symptoms not reported include lung disease and skin problems.",Hereditary metabolic disorders
['PMM2-CDG'],"+1 Cerebellar agenesis: This diagnosis aligns with cerebellar atrophy, ataxia, and hypotonia. Key symptoms not reported include severe developmental delays and potential seizures.
+2 Pontocerebellar hypoplasia: Fits with ataxia, hypotonia, and intellectual disability. Key symptoms not reported may include specific motor skill delays and additional neurological deficits.
+3 Miller-Dieker syndrome: Consistent with intellectual disability, abnormal facial shape, and hypotonia. Key symptoms not reported include seizures and specific brain malformations.
+4 Lissencephaly: Matches with intellectual disability and hypotonia. Key symptoms not reported include severe developmental delays and potential feeding difficulties.
+5 22q11.2 deletion syndrome: Could explain hypotonia and abnormal facial shape. Key symptoms not reported include cardiac defects and immune system issues.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Phenylketonuria (PKU): This condition is consistent with hyperphenylalaninemia. Key symptoms not reported include neurological impairment and developmental delays.
+2 Tyrosinemia: This diagnosis aligns with hypertyrosinemia and could explain the severe outcomes. Key symptoms not reported include liver dysfunction and renal issues.
+3 Maple Syrup Urine Disease (MSUD): This condition could explain some metabolic disturbances but does not directly correlate with hyperphenylalaninemia. Key symptoms not reported include characteristic urine odor and neurological symptoms.
+4 Urea Cycle Disorder: This could explain some metabolic derangements but does not specifically account for the hyperphenylalaninemia or hypertyrosinemia. Key symptoms not reported include hyperammonemia and associated neurological symptoms.
+5 Genetic Syndromes (e.g., Alkaptonuria): These could be considered but may not fit all symptoms. Key symptoms not reported include joint issues and dark urine.",Hereditary metabolic disorders
['Glutaryl-CoA dehydrogenase deficiency'],"+1 Glutaric Aciduria Type I: Symptoms consistent include macrocephaly, generalized hypotonia, abnormal cerebral morphology, and increased circulating lactate concentration. Key symptoms not reported may include episodes of metabolic crisis or acute neurological deterioration. 
+2 Mitochondrial Myopathy: Symptoms consistent include generalized hypotonia and increased circulating lactate concentration. Key symptoms not reported may include muscle weakness or exercise intolerance. 
+3 Urea Cycle Disorder: Symptoms consistent include abnormal circulating lysine concentration and generalized hypotonia. Key symptoms not reported may include hyperammonemia and altered mental status. 
+4 Organic Acidemia: Symptoms consistent include glutaric aciduria and abnormal metabolic markers. Key symptoms not reported may include metabolic acidosis or failure to thrive. 
+5 Peroxisomal Disorder: Symptoms consistent include macrocephaly and hypotonia. Key symptoms not reported may include developmental delays and specific dysmorphic features.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Phenylketonuria (PKU): Hyperphenylalaninemia, abnormality of prenatal development. Key symptoms not reported: Neurological impairment, developmental delay.
+2 Tyrosinemia: Hypertyrosinemia, neonatal death, death in childhood. Key symptoms not reported: Liver dysfunction, failure to thrive.
+3 Maple Syrup Urine Disease (MSUD): Abnormality of prenatal development, death in infancy. Key symptoms not reported: Sweet-smelling urine, neurological symptoms.
+4 Urea Cycle Disorders: Death in infancy, abnormality of prenatal development. Key symptoms not reported: Hyperammonemia, lethargy.
+5 Congenital Disorders of Glycosylation: Abnormality of prenatal development, death in infancy. Key symptoms not reported: Hypotonia, failure to thrive.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Congenital Cytomegalovirus Infection: Symptoms consistent include microcephaly, small for gestational age, and feeding difficulties. Key symptoms not reported may include hearing loss and vision problems. 
+2 Tyrosinemia: Symptoms consistent include hypertyrosinemia and severe short stature. Key symptoms not reported may include liver dysfunction and renal issues. 
+3 Phenylketonuria (PKU): Symptoms consistent include hyperphenylalaninemia and feeding difficulties. Key symptoms not reported may include developmental delays and behavioral issues. 
+4 Congenital Heart Defects: Symptoms consistent include pericardial effusion and feeding difficulties. Key symptoms not reported may include cyanosis and respiratory distress. 
+5 Genetic Syndromes (e.g., Down Syndrome, Turner Syndrome): Symptoms consistent include microcephaly and short stature. Key symptoms not reported may include characteristic facial features and other congenital anomalies.",Hereditary metabolic disorders
['Ornithine transcarbamylase deficiency'],"+1 Ornithine transcarbamylase deficiency: This condition is characterized by hyperammonemia, orotic aciduria, and can lead to vomiting. Key symptoms not reported include neurological deficits or seizures.
+2 Carbamoyl phosphate synthetase I deficiency: Similar to OTC deficiency, this condition leads to hyperammonemia and orotic aciduria. Key symptoms not reported include severe metabolic acidosis.
+3 Citrullinemia: This condition can cause hyperammonemia and vomiting, but typically does not present with orotic aciduria. Key symptoms not reported include elevated citrulline levels in plasma.
+4 Argininosuccinic aciduria: This condition can lead to hyperammonemia and vomiting, but orotic aciduria is not typically present. Key symptoms not reported include elevated argininosuccinic acid in urine.
+5 Urea cycle disorder (general): This encompasses a range of conditions that can lead to hyperammonemia and vomiting. Key symptoms not reported include specific enzyme deficiencies that could be identified through testing.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Phenylketonuria (PKU): Symptoms consistent include Hyperphenylalaninemia and Abnormal circulating tyrosine concentration. Key symptoms not reported include neurological deficits if untreated.
+2 Tyrosinemia: Symptoms consistent include Abnormal circulating tyrosine concentration and potential obesity. Key symptoms not reported include liver dysfunction and renal issues.
+3 Maple Syrup Urine Disease (MSUD): Symptoms consistent include Elevated urinary carboxylic acid. Key symptoms not reported include neurological symptoms and metabolic crises in infancy.
+4 Urea Cycle Disorders: Symptoms consistent include Death in infancy and early adulthood. Key symptoms not reported include hyperammonemia and specific amino acid imbalances.
+5 Congenital Disorders of Glycosylation: Symptoms consistent include Abnormality of prenatal development or birth and obesity. Key symptoms not reported include developmental delays and specific metabolic derangements.",Hereditary metabolic disorders
['Pearson syndrome'],"+1 Organic acidemia: This diagnosis is supported by the presence of 3-methylglutaric aciduria and increased lactate and pyruvate levels. Key symptoms not reported include metabolic acidosis and specific neurological deficits. 
+2 Mitochondrial disorder: The increased lactate and pyruvate levels, along with lethargy and coma, suggest mitochondrial dysfunction. Key symptoms not reported include muscle weakness and exercise intolerance. 
+3 Urea cycle disorder: The lethargy, coma, and metabolic derangements could indicate a urea cycle defect. Key symptoms not reported include hyperammonemia and specific neurological symptoms. 
+4 Cystic fibrosis: The exocrine pancreatic insufficiency and recurrent infections suggest cystic fibrosis, but the renal involvement is atypical. Key symptoms not reported include chronic respiratory issues and failure to thrive. 
+5 Fanconi syndrome: The renal Fanconi syndrome explains kidney enlargement and metabolic issues. Key symptoms not reported include specific electrolyte imbalances and growth retardation.",Hereditary metabolic disorders
['Smith-Lemli-Opitz syndrome'],"+1 Smith-Lemli-Opitz Syndrome (SLOS): Broad philtrum, long philtrum, anteverted nares, syndactyly, generalized hypotonia, hypocholesterolemia, elevated 8-dehydrocholesterol, elevated 7-dehydrocholesterol. Key symptoms not reported: Behavioral issues, intellectual disability. 
+2 Congenital Syndromes (e.g., Apert syndrome): Broad philtrum, syndactyly, hypotonia. Key symptoms not reported: Craniosynostosis, hearing loss. 
+3 Down Syndrome: Hypotonia, feeding difficulties, broad philtrum. Key symptoms not reported: Distinctive facial features, congenital heart defects. 
+4 Cornelia de Lange Syndrome: Broad and long philtrum, hypotonia, feeding difficulties. Key symptoms not reported: Limb malformations, growth delays. 
+5 22q11.2 Deletion Syndrome: Hypotonia, feeding difficulties, facial dysmorphisms. Key symptoms not reported: Cardiac defects, immune deficiencies.",Hereditary metabolic disorders
['Acute intermittent porphyria'],"+1 Severe Combined Immunodeficiency (SCID): Recurrent viral infections, vomiting, abdominal pain. Key symptoms not reported: Severe respiratory infections, failure to thrive. 
+2 Cystic Fibrosis: Vomiting, abdominal pain, recurrent infections. Key symptoms not reported: Chronic cough, salty skin, pancreatic insufficiency. 
+3 Chronic Granulomatous Disease (CGD): Recurrent infections, abdominal pain, vomiting. Key symptoms not reported: Granulomas, particularly in the lungs or liver. 
+4 Hyper-IgE Syndrome (Job's Syndrome): Recurrent infections, vomiting, abdominal pain. Key symptoms not reported: Eczema, elevated IgE levels. 
+5 Wiskott-Aldrich Syndrome: Recurrent infections, vomiting, abdominal pain. Key symptoms not reported: Eczema, low platelet count.",Hereditary metabolic disorders
['Citrullinemia type I'],"+1 Citrullinemia: This condition is characterized by elevated plasma citrulline and hyperammonemia, consistent with the patient's symptoms. Key symptoms not reported include neurological deficits or developmental delays.
+2 Ornithine Transcarbamylase Deficiency: This urea cycle disorder can lead to hyperammonemia and metabolic acidosis. The patient’s elevated citrulline supports this, but the specific amino acid profile leans more towards citrullinemia. Key symptoms not reported include acute hyperammonemic crises.
+3 Argininosuccinic Aciduria: This condition can present with elevated citrulline and hyperammonemia. The presence of argininuria supports this diagnosis. Key symptoms not reported include failure to thrive and neurological symptoms.
+4 Hyperglycinemia: While hyperglycinuria is noted, the absence of other symptoms makes this less likely. Key symptoms not reported include seizures or lethargy.
+5 Urea Cycle Disorder (general): This encompasses various conditions, but the specific findings point more towards citrullinemia or OTC deficiency. Key symptoms not reported include recurrent vomiting or lethargy during metabolic crises.",Hereditary metabolic disorders
[],"+1 Methylmalonic Acidemia: Symptoms consistent include hyperammonemia, methylmalonic acidemia, lethargy, hypotonia, and developmental delays. Key symptoms not reported include metabolic crises or acidosis episodes.
+2 Urea Cycle Disorder: Symptoms consistent include hyperammonemia and neurological symptoms. Key symptoms not reported include specific amino acid imbalances or acute metabolic decompensation.
+3 Homocystinuria: Symptoms consistent include hyperhomocystinemia and developmental delays. Key symptoms not reported include lens dislocation and skeletal abnormalities.
+4 Propionic Acidemia: Symptoms consistent include lethargy and hypotonia. Key symptoms not reported include metabolic acidosis and specific organic acid findings in urine.
+5 Mitochondrial Disorder: Symptoms consistent include lethargy and hypotonia. Key symptoms not reported include specific mitochondrial dysfunction markers or exercise intolerance.",Hereditary metabolic disorders
['Very long chain acyl-CoA dehydrogenase deficiency'],"+1 Urea Cycle Disorder: Hyperammonemia, hypotonia, and neurological symptoms. Key symptoms not reported include specific neurological deficits or seizures.
+2 Fatty Acid Oxidation Disorder: Decreased plasma free carnitine, hypotonia, and metabolic derangements. Key symptoms not reported include episodes of hypoglycemia or muscle pain.
+3 Maple Syrup Urine Disease: Abnormal circulating amino acid concentrations. Key symptoms not reported include characteristic sweet-smelling urine and developmental delays.
+4 Organic Acidemia: Abnormal amino acid concentrations and hypotonia. Key symptoms not reported include metabolic acidosis or specific organic aciduria.
+5 Mitochondrial Disorder: Hypotonia and metabolic issues. Key symptoms not reported include exercise intolerance or specific neurological symptoms.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Congenital Heart Defect: This could explain the abnormality of prenatal development, upper airway obstruction, and high mortality in infancy. Key symptoms not reported include cyanosis or heart murmurs. 
+2 Phenylketonuria (PKU): Consistent with hyperphenylalaninemia. Symptoms not reported include developmental delays or neurological issues. 
+3 Tyrosinemia: Aligns with hypertyrosinemia. Symptoms not reported include liver dysfunction or renal issues. 
+4 Congenital Airway Malformation: This could explain upper airway obstruction and chronic pulmonary obstruction. Key symptoms not reported include stridor or respiratory distress. 
+5 Smith-Lemli-Opitz Syndrome: This genetic syndrome could account for multiple developmental abnormalities and metabolic issues. Symptoms not reported include dysmorphic features or behavioral issues.",Hereditary metabolic disorders
['Medium chain acyl-CoA dehydrogenase deficiency'],"+1 Organic acidemia: This condition could explain the metabolic derangements, including decreased carnitine and abnormal vitamin B12 levels. Key symptoms not reported include metabolic acidosis and developmental delays.
+2 Mitochondrial disorder: The decreased 3-hydroxyacyl-CoA dehydrogenase level suggests a fatty acid oxidation issue. Key symptoms not reported include exercise intolerance and myopathy.
+3 Urea cycle disorder: This could lead to neurological symptoms and early mortality. Key symptoms not reported include hyperammonemia and lethargy.
+4 Cerebral palsy due to perinatal asphyxia: The spasticity and history of premature birth fit this diagnosis. Key symptoms not reported include seizures and developmental delays.
+5 Severe combined immunodeficiency (SCID): The combination of severe symptoms and early mortality could suggest this diagnosis. Key symptoms not reported include recurrent infections and failure to thrive.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Tyrosinemia Type I: Symptoms include hypertyrosinemia and potential liver dysfunction. Key symptoms not reported include jaundice and failure to thrive. 
+2 Phenylketonuria (PKU): Symptoms include hyperphenylalaninemia and neurological impairment. Key symptoms not reported include developmental delays and behavioral issues. 
+3 Maple Syrup Urine Disease (MSUD): Symptoms include elevated branched-chain amino acids and neurological damage. Key symptoms not reported include sweet-smelling urine and feeding difficulties. 
+4 Urea Cycle Disorders: Symptoms include hyperammonemia and neurological symptoms. Key symptoms not reported include lethargy and vomiting. 
+5 Combined Immunodeficiency: Symptoms include recurrent infections. Key symptoms not reported include failure to thrive and chronic diarrhea.",Hereditary metabolic disorders
['3-methylcrotonyl-CoA carboxylase deficiency'],"+1 Non-ketotic hyperglycinemia (NKH): This condition is consistent with elevated glycine levels, aminoaciduria, and can lead to death in infancy. Key symptoms not reported include seizures and hypotonia.
+2 Propionic acidemia: This diagnosis fits with elevated urinary carboxylic acid but does not explain the abnormal glycine concentration. Key symptoms not reported include metabolic acidosis and developmental delays.
+3 Isovaleric acidemia: This condition is associated with elevated carboxylic acids but does not explain the glycine levels. Key symptoms not reported include a characteristic odor of sweat and metabolic crises.
+4 Maple syrup urine disease (MSUD): This diagnosis aligns with aminoaciduria but does not explain the glycine levels. Key symptoms not reported include a sweet-smelling urine and neurological symptoms.
+5 Glycine encephalopathy: This is synonymous with non-ketotic hyperglycinemia and fits the symptoms well. Key symptoms not reported include severe developmental delays and lethargy.",Hereditary metabolic disorders
['Succinic semialdehyde dehydrogenase deficiency'],"+1: Organic Acidemia: Symptoms consistent include elevated urinary carboxylic acid, seizures, ataxia, motor delay, and hypotonia. Key symptoms not reported may include metabolic crises or acidosis.
+2: Urea Cycle Disorder: Symptoms consistent include elevated carboxylic acid and neurological symptoms. Key symptoms not reported may include hyperammonemia or specific metabolic derangements.
+3: Mitochondrial Disorder: Symptoms consistent include seizures, hypotonia, and developmental delays. Key symptoms not reported may include exercise intolerance or specific mitochondrial myopathy features.
+4: Lysosomal Storage Disorder: Symptoms consistent include hypotonia, seizures, and developmental delays. Key symptoms not reported may include specific storage features or organomegaly.
+5: Autism Spectrum Disorder: Symptoms consistent include delayed speech and hyperactivity. Key symptoms not reported may include social communication deficits or repetitive behaviors.",Hereditary metabolic disorders
['Argininosuccinic aciduria'],"+1 Organic Acidemia: This condition can lead to metabolic acidosis, vomiting, tachycardia, and hepatomegaly. Key symptoms not reported include specific metabolic derangements in urine.
+2 Fatty Acid Oxidation Disorder: Symptoms consistent with metabolic acidosis, tachycardia, and hepatomegaly. Key symptoms not reported include hypoglycemia or episodes of fasting intolerance.
+3 Urea Cycle Disorder: Metabolic acidosis and tachycardia are consistent, but the absence of neurological symptoms makes this less likely. Key symptoms not reported include hyperammonemia.
+4 Galactosemia: Can cause hepatomegaly and metabolic acidosis, particularly after milk ingestion. Key symptoms not reported include jaundice or specific feeding history.
+5 Mitochondrial Disorder: Symptoms of metabolic acidosis and tachycardia align, but typically have broader systemic involvement. Key symptoms not reported include exercise intolerance or developmental delays.",Hereditary metabolic disorders
['Gyrate atrophy of choroid and retina'],"+1 Urea Cycle Disorder: Hyperammonemia, hypoargininemia, hyperornithinemia, severe short stature. Key symptoms not reported: Neurological deficits, seizures. 
+2 Non-ketotic Hyperglycinemia: Hyperglycinemia, feeding difficulties, potential neurological involvement. Key symptoms not reported: Seizures, developmental delays. 
+3 Citrullinemia: Hyperammonemia, severe short stature, potential neurological symptoms. Key symptoms not reported: Specific amino acid imbalances. 
+4 Argininosuccinic Aciduria: Hyperammonemia, feeding difficulties, severe short stature. Key symptoms not reported: Specific metabolic crises. 
+5 Mitochondrial Disorder: Anemia, malabsorption, severe short stature. Key symptoms not reported: Muscle weakness, exercise intolerance.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Phenylketonuria (PKU): Hyperphenylalaninemia, abnormality of prenatal development or birth. Key symptoms not reported: Neurological impairment, developmental delays.
+2 Tyrosinemia: Hypertyrosinemia, abnormality of prenatal development or birth. Key symptoms not reported: Liver dysfunction, renal issues.
+3 Maple Syrup Urine Disease (MSUD): Death in infancy, abnormality of prenatal development or birth. Key symptoms not reported: Sweet-smelling urine, neurological symptoms.
+4 Urea Cycle Disorders: Death in infancy, neonatal death. Key symptoms not reported: Hyperammonemia, vomiting, lethargy.
+5 Congenital Disorders of Glycosylation (CDG): Abnormality of prenatal development or birth, death in childhood. Key symptoms not reported: Multisystem involvement, developmental delays.",Hereditary metabolic disorders
['Carbamoyl-phosphate synthetase 1 deficiency'],"+1 Urea Cycle Disorder: This condition is characterized by hyperammonemia, feeding difficulties, and hypotonia. Key symptoms not reported include seizures or altered consciousness during metabolic crises. 
+2 Organic Acidemia: This includes conditions like propionic acidemia, which can cause hypotonia, feeding difficulties, and metabolic crises leading to hyperammonemia. Key symptoms not reported may include metabolic acidosis or specific odor in urine. 
+3 Mitochondrial Disorder: These disorders can present with hypotonia and neurological symptoms, but hyperammonemia is less common. Key symptoms not reported include exercise intolerance or myopathy. 
+4 Severe Combined Immunodeficiency (SCID): While primarily an immune disorder, some forms can lead to hypotonia and metabolic issues. Key symptoms not reported include recurrent infections or failure to thrive. 
+5 Lysosomal Storage Disorder: These can present with hypotonia and neurological decline, but hyperammonemia is not typical. Key symptoms not reported include hepatosplenomegaly or specific storage features on imaging.",Hereditary metabolic disorders
['Canavan disease'],"+1 Krabbe disease: This leukodystrophy explains the abnormal myelination, generalized hypotonia, seizures, and could account for the neonatal death. Key symptoms not reported include irritability and feeding difficulties in early infancy.
+2 Leigh syndrome: A mitochondrial disorder that could explain the neurological symptoms, hypotonia, and seizures. Key symptoms not reported include respiratory issues and progressive neurological decline.
+3 Congenital cytomegalovirus infection: This could account for the hearing impairment and neurological symptoms. Key symptoms not reported include microcephaly and other systemic manifestations.
+4 Aminoacidopathy: A metabolic disorder could explain the abnormal amino acid concentrations and neurological symptoms. Key symptoms not reported include specific metabolic crises or developmental delays.
+5 Bardet-Biedl syndrome: This genetic disorder could explain the blindness and hearing impairment. Key symptoms not reported include obesity and polydactyly, which are typically associated with this condition.",Hereditary metabolic disorders
"['Methylmalonic acidemia with homocystinuria, type cblC']","+1 Methylmalonic acidemia: Symptoms consistent include methylmalonic aciduria, intellectual disability, and dyskinesia. Key symptoms not reported may include metabolic crises or failure to thrive. 
+2 Congenital cytomegalovirus infection: Symptoms consistent include microcephaly, strabismus, and intellectual disability. Key symptoms not reported may include hearing loss or other organ involvement. 
+3 Smith-Lemli-Opitz syndrome: Symptoms consistent include microcephaly, strabismus, and developmental delays. Key symptoms not reported may include characteristic facial features or limb malformations. 
+4 Hydrocephalus due to congenital malformations: Symptoms consistent include hydrocephalus, microcephaly, and intellectual disability. Key symptoms not reported may include specific congenital anomalies or signs of increased intracranial pressure. 
+5 Genetic syndromes associated with dyskinesia: Symptoms consistent include dyskinesia, intellectual disability, and respiratory insufficiency. Key symptoms not reported may include specific movement disorders or additional neurological deficits.",Hereditary metabolic disorders
['Medium chain acyl-CoA dehydrogenase deficiency'],"+1 Medium-chain acyl-CoA dehydrogenase deficiency (MCADD): Symptoms consistent include ""Decreased 3-hydroxyacyl-CoA dehydrogenase level,"" ""Vomiting,"" and ""Death in infancy."" Key symptoms not reported include hypoglycemia and lethargy during metabolic crises. 
+2 Fatty acid oxidation disorders: Symptoms consistent include ""Vomiting,"" ""Gastrointestinal inflammation,"" and ""Abnormal circulating carnitine concentration."" Key symptoms not reported include hypoketotic hypoglycemia and metabolic acidosis. 
+3 Congenital adrenal hyperplasia (CAH): Symptoms consistent include ""Abnormality of prenatal development or birth"" and ""Gastrointestinal inflammation."" Key symptoms not reported include ambiguous genitalia in females and adrenal crisis. 
+4 Mitochondrial disorders: Symptoms consistent include ""Abnormality of prenatal development or birth"" and ""Death in infancy."" Key symptoms not reported include muscle weakness and neurological symptoms. 
+5 Inborn errors of metabolism: Symptoms consistent include ""Vomiting,"" ""Gastrointestinal inflammation,"" and ""Abnormality of prenatal development or birth."" Key symptoms not reported include developmental delays and failure to thrive.",Hereditary metabolic disorders
['Biotinidase deficiency'],"+1 Urea Cycle Disorder: This condition is consistent with hyperammonemia, metabolic acidosis, and hypotonia. Key symptoms not reported include seizures or neurological deficits. 
+2 Organic Acidemia: Symptoms align with metabolic acidosis and hypotonia. Key symptoms not reported may include vomiting or lethargy. 
+3 Severe Combined Immunodeficiency (SCID): Leukopenia and hypotonia are consistent, but hyperammonemia is atypical. Key symptoms not reported include recurrent infections. 
+4 Mitochondrial Disorder: Hypotonia and metabolic acidosis are present, but hyperammonemia is less typical. Key symptoms not reported may include developmental delays or seizures. 
+5 Peroxisomal Disorders: Hypotonia and metabolic disturbances are present, but hyperammonemia is atypical. Key symptoms not reported may include neurological decline or adrenal insufficiency.",Hereditary metabolic disorders
['Tyrosinemia type 2'],"+1 Tyrosinemia Type I: Symptoms include hypertyrosinemia, intellectual disability, seizures, keratitis, and conjunctivitis. Key symptoms not reported include liver dysfunction and renal issues.
+2 Bardet-Biedl Syndrome: Symptoms include intellectual disability, photophobia, and potential ocular issues. Key symptoms not reported include obesity and polydactyly.
+3 Cystinosis: Symptoms include photophobia, keratitis, and potential neurological issues. Key symptoms not reported include renal failure and growth retardation.
+4 Galactosemia: Symptoms include intellectual disability and potential ocular issues. Key symptoms not reported include jaundice and feeding difficulties in infancy.
+5 Mitochondrial disorders: Symptoms include seizures and potential ocular issues. Key symptoms not reported include muscle weakness and exercise intolerance.",Hereditary metabolic disorders
['Phenylketonuria'],"+1 Phenylketonuria (PKU): Consistent symptoms include hyperphenylalaninemia and abnormal tyrosine concentration. Key symptoms not reported include developmental delays and intellectual disability.
+2 Tyrosinemia: Consistent symptoms include abnormal circulating tyrosine concentration. Key symptoms not reported include liver dysfunction and renal issues.
+3 Maple Syrup Urine Disease (MSUD): Consistent symptoms include abnormal amino acid levels. Key symptoms not reported include characteristic sweet-smelling urine and neurological symptoms.
+4 Urea Cycle Disorders: Consistent symptoms include potential metabolic crisis leading to death. Key symptoms not reported include hyperammonemia and neurological symptoms.
+5 Other Genetic Metabolic Disorders: Consistent symptoms include abnormal prenatal development and early mortality. Key symptoms not reported include specific metabolic derangements depending on the disorder.",Hereditary metabolic disorders
[],"+1 Urea Cycle Disorder: This condition is consistent with hyperammonemia, seizures, and the history of neonatal death. Key symptoms not reported include lethargy and vomiting.
+2 Organic Acidemia: The presence of 3-hydroxydicarboxylic aciduria aligns with this diagnosis, along with seizures and cyanosis. Key symptoms not reported may include metabolic acidosis and failure to thrive.
+3 Fatty Acid Oxidation Disorder: This could explain the seizures and metabolic derangements. Key symptoms not reported include hypoglycemia and muscle weakness.
+4 Mitochondrial Disorder: This could account for the seizures and metabolic issues, with potential for early death. Key symptoms not reported include developmental delays and exercise intolerance.
+5 Cardiac or Respiratory Failure: While less likely, severe cyanosis could indicate this. Key symptoms not reported include shortness of breath and abnormal heart sounds.",Hereditary metabolic disorders
['Alkaptonuria'],"+1 Urea Cycle Disorder: Vomiting, dark urine. Key symptoms not reported: lethargy, seizures. 
+2 Bile Acid Synthesis Disorder: Dark urine, vomiting. Key symptoms not reported: jaundice, failure to thrive. 
+3 Galactosemia: Vomiting, dark urine. Key symptoms not reported: jaundice, cataracts. 
+4 Tyrosinemia: Vomiting, dark urine. Key symptoms not reported: failure to thrive, liver dysfunction. 
+5 Inborn Errors of Metabolism: Vomiting, dark urine. Key symptoms not reported: developmental delays, metabolic crises.",Hereditary metabolic disorders
['Maple syrup urine disease'],"+1 Urea Cycle Disorder: Symptoms include hyperammonemia, lethargy, seizures, and growth delay. Key symptoms not reported include vomiting and irritability.
+2 Maple Syrup Urine Disease (MSUD): Symptoms include elevated branched-chain amino acids, lethargy, seizures, and feeding difficulties. Key symptoms not reported include a characteristic sweet odor in urine.
+3 Organic Acidemia: Symptoms include metabolic acidosis, hyperammonemia, and lethargy. Key symptoms not reported include developmental delays and specific metabolic crises.
+4 Propionic Acidemia: Symptoms include metabolic acidosis, lethargy, and seizures. Key symptoms not reported include vomiting and hypotonia.
+5 Isovaleric Acidemia: Symptoms include metabolic acidosis, lethargy, and feeding difficulties. Key symptoms not reported include a characteristic odor of sweaty feet.",Hereditary metabolic disorders
['Ornithine transcarbamylase deficiency'],"+1 Urea Cycle Disorder (e.g., Ornithine Transcarbamylase Deficiency): Symptoms include hyperammonemia, coma, generalized hypotonia, and elevated plasma citrulline. Key symptoms not reported include specific neurological deficits or seizures.

+2 Organic Acidemia (e.g., Propionic Acidemia): Symptoms include vomiting, hypotonia, and metabolic crises. Key symptoms not reported include specific metabolic acidosis or ketonuria.

+3 Amino Acid Metabolism Disorder (e.g., Citrullinemia): Symptoms include elevated plasma citrulline and neurological impairment. Key symptoms not reported include specific developmental delays or seizures.

+4 Mitochondrial Disorder: Symptoms include hypotonia and neurological symptoms. Key symptoms not reported include myopathy or specific mitochondrial dysfunction markers.

+5 Inborn Error of Metabolism (e.g., Maple Syrup Urine Disease): Symptoms include vomiting and neurological impairment. Key symptoms not reported include characteristic urine odor or specific amino acid abnormalities.",Hereditary metabolic disorders
